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  ivAbstract 
 
 
The Plp1 gene encodes the two proteins DM20 and PLP. Ultrastructural techniques will 
provide the best resolution to establish the sub-cellular localisation of the two myelin 
protein isoforms encoded by the Plp1 gene in mice and thus provide insight into the 
functions for the two isoforms. The gene is expressed primarily by oligodendroglia of 
the central nervous system (CNS), with some expression (primarily of DM20) in the 
Schwann cells of the peripheral nervous system. In the CNS, the DM20 isoform is 
expressed initially prior to myelin initiation and expression maintained throughout life. 
The function of DM20 is unknown. The expression of the PLP isoform appears to be 
related to myelination and have a structural role in compact myelin. The objective was 
to establish an immunolocalisation technique which would allow the hypothesis to be 
tested that DM20 is expressed in non-compacted regions of the myelinating 
oligodendrocyte, whilst PLP expression is confined to the compact myelin sheath. In 
order to differentially label PLP and DM20 at the paranodal region of myelinated axons, 
two different immunological techniques suitable for subcellular localisation were 
investigated.   
The photo-oxidation technique was applied to both cerebellar and cervical spinal cord 
vibratome sections. A brominated eosin conjugated secondary antibody was created and 
used to label a primary antibody against PLP and DM20. The photo-oxidation 
technique, a pre-embedding immunostaining, generated a very fine reaction product that 
was excellent at light microscopic resolution but only visible at electron microscopic 
resolution in sections that were not contrast stained.   
The immunogold technique was applied to sections from ventral columns in cervical 
spinal cord which has a dense population of medium to large myelinated axons. 
Assessments were made using anti-PLP antibodies in mature animals (with PLP at its 
peak of production and the myelin compacted and well established) and in young 
animals (with PLP in its beginning of production and less compacted). The immunogold 
technique, a post-embedding immuno-staining, produced a well-defined electron dense 
particle that was easily visualised in the EM. The technique proved insufficient to 
  vdifferentiate two different PLP antibodies, one labelling both isoforms (i.e. PLP and 
DM20) and the other specifically labelling only PLP. A substantially higher level of 
labelling was achieved, uniquely using the freeze substitution method of tissue 
preservation; however quantitative analysis could not be carried out because 
preservation was inconsistent both within the same tissue and from sample to sample.
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CHAPTER 1   INTRODUCTION 
 
 
1.1   BACKGROUND AND LITERATURE REVIEW 
A knowledge of neuroanatomy and an understanding of intracellular and extracellular 
relationships is of vital importance when undertaking any electron microscopic study of 
the central nervous system.   Equally, awareness of the functions of different cells and 
their components forms a basis from which to elucidate findings on a subcellular level.   
Although both these areas are being vigorously investigated and are constantly changing, 
the basic facts have remained remarkably unchanged. 
The nervous system is functionally divided into a somatic and an autonomic system where 
the somatic system regulates conscious processes e.g.   activities of skeletal musculature 
and the autonomic system regulates activities of inner organs, smooth muscle and glands.   
Anatomically, the nervous system is divided into the central and peripheral nervous 
system (CNS and PNS).   The CNS consists of the brain and spinal cord and the PNS 
consists of ganglia and nerves spread throughout the body. 
The CNS is a complex heterogeneous organ sequestered from the rest of the body by the 
blood brain barrier.   It is also protected by a triple layer of membranes called the 
meninges.   The outermost membrane is the dura mater, next is the arachnoid and 
innermost, the pia mater loosely covers the surface of the CNS.   The dura mater is derived 
from the mesoderm; the arachnoid and pia mater are derived from the ectoderm and are 
together called the leptomeninges.   Circulating throughout the ventricular and sub-
arachnoid space is cerebrospinal fluid (CSF), which protects the CNS from mechanical 
trauma and maintains the ventricular pressure.    
Macroscopically, the CNS is intricately folded around five ventricles and in the forebrain 
reveals a rim of gray matter, the cortex, overlying an inner white matter which is 
interspersed with islands of more gray matter.   This situation is reversed in brain stem and 
spinal cord where the dorsal and ventral horns with the central canal in the centre form an 
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H shaped configuration of gray matter surrounded by white matter.   The white matter 
contains myelinated nerve fibres where the lipid component of the myelin is responsible 
for its whiteness.   The gray matter consists mainly of nerve cell bodies and glia. 
The major components of the CNS and their interrelationships have extensively been 
investigated and recorded.   Briefly, on the microscopic level, the pia-astroglia (glia 
limitans) provides the barrier between the exterior and the CNS parenchyma.   The 
neurons and its processes together with astrocytes, oligodendrocytes and microglia 
interspersed with blood vessels forms the parenchyma (for an excellent introduction to 
cellular morphology in the CNS, see Raine, 1994).    
 
1.2   NEURONS 
The neuron consists of a cell body (perikaryon) with one or more cytoplasmic processes.   
The large variety of neurons can be subdivided by size, ranging from the small cerebellar 
granule cells with a perikaryal diameter of 5 to 8 µm to the larger pear shaped Purkinje 
cells and the star shaped anterior horn cells both of which can reach diameter of up to 80 
µm in humans.   The size and shape of the neurones were initially established as early as 
1839 by Purkinje and further explored by Deiters , Ramón y Cajal and Golgi in the late 
nineteenth century and early twentieth century (see Raine, 1994 for a historical 
perspective). 
The shape of the neurons varies greatly and is largely dependent on the amount and 
arrangement of its processes.   Morphologically, neurons are sub-classified into unipolar, 
bipolar and multipolar.   There are two types of perikaryal processes, axons or dendrites.   
Dendrites are usually short branching processes whereas axons are long and unbranched 
except at the terminals.     
The cytoarchitectural features of the perikaryon reveal a large spherical shaped nucleus, 
usually situated centrally, well developed rough endoplasmic reticulum (ER), prominent 
Golgi apparatus and abundant mitochondria (Fig.1.1).   Lysosomes, peroxisomes and 
multivesicular bodies are frequently visible.   
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         FIGURE 1.1  Electron micrograph of a neuron (Purkinje cell), flanked by basket 
cells, from the cerebellar grey matter of an adult mouse. The nucleus (Nu) has a 
central orientation in the cellbody. Note the rich organelle filled cytoplasm with 
well developed rough endoplasmic reticulum, abundant mitochondria, as well as 
the striking basophilic Nissl substance (see enlarged inset). Part of the axon 
hillock can be seen at the bottom of the picture (arrow) with organelles aligning in 
a longitudinal fashion (McCulloch, unpublished observation). 
         Scale bar = 5µm.
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A characteristic feature for nerve cells is the abundant basophilic Nissl substance.   It 
consists of tightly packed membranes and sacs from the ER with ribosomes both attached 
and freely interspersed, sometimes clumped together, so called polyribosomes.   The 
organization of Nissl bodies in the perikaryal cytoplasm and dendrites is varied and often 
form a characteristic pattern, which is used as a criterion for neuron identification.   The 
Nissl substance is however missing in axons and the axon hillock (the area where the axon 
emerges from the perikaryon). 
The neuronal cytoskeleton consists of neurofilaments, microtubules and intermediate 
filaments.   These are arranged in many directions in the perikaryon but are aligned 
longitudinally in the axon and dendrites 
Axons are the elongated processes of the neurons that pass information from the 
perikaryon to other cells.   The most prominent and consistent feature of large axons is 
neurofilaments that run parallel to the long axis of the axon.   The ~100 Å neurofilaments 
are less common in small axons where microtubules, a larger cylindrical 200 – 250 Å 
structure, are more frequent.   Neurofilaments play a major role in determining the shape 
and diameter of the axons while microtubules are involved in axonal transport. 
 
1.3   ASTROCYTES 
The nervous tissue consists not only of neurones and their processes but also of glial cells 
which surrounds them throughout the nervous system.   It was Virchow who in 1846 first 
discovered a non-nervous component, which he called neuroglia from the Greek words 
meaning “nerve” and “glue” but it was not until the early twentieth century when the 
Spanish histologists Ramon y Cajal and del Rio Hortega who, with their metallic 
impregnation techniques, established and classified the neuroglia as distinct cells (for a 
historical perspective see Privat et al, 1995). 
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Today three groups of glia are recognised: 
1.   macroglia, which consists of astrocytes and oligodendrocytes.   The macroglia  
originate from ectodermal stem cells called spongioblasts. 
2.   microglia, of mesodermal origin. 
3.   ependymal cells, also of ectodermal spongioblasts. 
Glial cells retain their ability to divide throughout their life and possess no synaptic 
contacts. 
Astrocytes are traditionally subdivided into protoplasmic and fibrous astrocytes (Mugnani 
and Walberg, 1964) though there are a large variety of transitional cells differing in 
location, function and to some extent morphology.   Radial cells (e.g.   Bergmann glia and 
Müller glia) are considered by some a distinct group (Privat et al, 1995).     There is also 
growing evidence that protoplasmic and fibrous astrocytes are derived from different 
progenitors; Raff et al (1983) suggested that fibrous astrocytes were derived from the same 
progenitor as oligodendrocytes.   Both types of astrocyte contain all normal organelles 
found in eukaryotic cells, but are sparser than in other glia.   The most prominent 
cytoplasmic components of the astrocyte are filaments 9 nm in diameter, which occur in 
the perikarya and extend into the processes (Fig.1.2).   These filaments closely resemble 
intermediate filaments found in neurons, however their dimensions are smaller and they 
regularly appear as closely packed bundles.   Protoplasmic astrocytes range in size from 10 
to 40 µm and are located mostly in grey matter, frequently abutting capillaries.   They have 
a clearer cytoplasm than fibrous astrocytes.   Characteristic for both types is a large, ovoid 
nucleus with homogenous chromatin except for a narrow denser rim and one or two poorly 
defined nucleoli.   Fibrous astrocytes are located in white matter, with twig-like processes 
composed of a large number of 9 nm filaments arranged in bundles.   The filaments within 
these cell processes can be distinguished from neurofilaments by their close packing and 
the absence of side arms.   Desmosomes and gap junctions occur between adjacent 
astrocytic processes.   After trauma, astrocytes proliferate, swell, and accumulate glycogen 
and filaments.   If gliosis is total, all other elements are lost and a glial scar will form.     
Astrocytes have the ability to become macrophages in some diseases and astrocytes are 
probably the most disease-resistant component in the CNS because very few diseases  
(alcoholism is one exception) cause depletion of astrocytes (Raine, 1994). 
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FIGURE 1.2  Electron micrograph of an astrocyte from the optic nerve of an adult 
mouse surrounded by myelinated axons (Ax).   The astrocyte nucleus (Nu) usually 
has a more homogenous chromatin than is shown here but the thin rim of 
chromatin inside the nuclear envelope clearly distinguish astrocyte nuclei from 
other glia cells.  Characteristic for the astrocyte are the bundles of filaments (white 
arrows) which makes these cells easily recognisable.   Note the filament filled 
processes extending from the cell body, three of which are labelled (black arrows), 
demonstrating the typical starshape of the astrocyte.   Other cellular features are 
rough ER and Golgi apparatus (G).   (Griffiths, unpublished observation). 
         Scale bar = 2 µm.   
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Identification and localisation of astrocytes have become relatively easy and reliable 
through the advent of immunocytochemistry.   Many antigenic markers are now in use but 
the first and still foremost is glial fibrillary acidic protein (GFAP), discovered by Eng et al 
(1971) and Bignami et al (1972), the major protein associated with the astrocyte 
intermediate filaments.   Astrocytes have numerous other functions including regulation of 
the extracellular milieu through their ion channels, neurotransmitter receptors and 
transporters, modulation of synapses and production of growth factors. 
 
1.4   OLIGODENDROCYTES 
Oligodendrocytes are the second type of cells belonging to the subclass of macroglia.   
Their main function is myelination of axons in the CNS, although the more that is revealed 
about the oligodendrocytes the more complex these heterogeneous cells appear.   Rio 
Hortega first described oligodendrocytes in 1921 and gave them the name oligodendroglia 
meaning oligo= few, dendro=tree and glia=glue.   He later reviewed his findings and 
renamed them oligodendrocytes in recognition that they were cells in their own right and 
also categorised them into interfascicular, perineuronal and perivascular oligodendrocytes.   
Hortega furthermore subdivided oligodendrocytes into four types, numbered I through IV 
by characterising their polymorphism using criteria such as size of somata, number of 
processes, tissue distribution and the manner of interaction with axons.   This was later 
confirmed by Stensaas & Stensaas (1968a, b), who found the same results in toad with no 
transitional forms between I & II and III & IV.   Typically, oligodendrocytes type I and II 
myelinate multiple internodes on separate small diameter axons, sometimes as many as 40 
to 50 axons.   Type III and IV oligodendrocytes myelinate fewer axons of larger diameter 
with the latter type myelinating a single internode just as Schwann cells in the PNS (for a 
historical perspective of the field from Rio Hortega to current concepts, see Szuchet 1995). 
Ultrastructurally oligodendrocytes are moderately dense cells with a round or oval nucleus 
usually eccentrically located; some clumping of chromatin occurs with a thin rim just 
below the nuclear envelope.   The cytoplasm contains large numbers of ribosomes both 
free and attached to rough ER and a well-developed Golgi system.   Two features that 
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make oligodendrocytes readily identifiable are the lack of glycogen granules and 
intermediate filaments which are prominent features in astrocytes (Fig.1.3).   Microtubules 
are also a prominent feature of these cells.   In a study of corpus callosum in rats Mori & 
Leblond (1970) identified three classes of oligodendrocytes, i.e.   light, medium and dark.   
Light oligodendrocytes are the largest and contain most free ribosomes and were found to 
undergo mitosis;  dark oligodendrocytes are smallest with a rough ER and Golgi more 
prominent and with no evidence of mitosis.   The medium class of oligodendrocytes are 
intermediate with many features of the light but with fewer ribosomes and more limited 
mitosis.   The conclusion would be that these three classes are the representation of the 
oligodendrocytes lifecycle, light being young and dark being the old oligodendrocyte. 
1.4.1  BIOCHEMISTRY OF MYELIN 
 Biologically, CNS myelin is an extension of the oligodendrocyte plasma membrane.   
During myelination processes contact and wrap tightly around axons to form a compact 
lamellar structure.   Although myelin is a continuation of the oligodendrocyte its 
biochemical composition is complex and distinct (Szuchet et al, 1988) 
The major biochemical components of myelin are few and well documented.   Depending 
on species, lipids make up 70 – 85%, protein 15 – 30 % and gangliosides 0.5 % of myelin 
dry weight.  Minor proteins, splice products and post-translationally modified protein 
isoforms are numerous and the list of such proteins continues to grow as new techniques 
and molecular markers are discovered. 
The molecular architecture of myelin is hypothesised and is based on EM, 
immunohistochemical staining, X-ray diffraction, surface probe studies, structural 
abnormalities in mutant mice, correlations between structure and composition in various 
species and predictions of protein structure from sequencing information (for review see 
Kirchner and Blaurock, 1991). 
It is generally accepted that myelin consist of compaction of normal cell lipid bilayer 
membrane with proteins, some integral embedded some extrinsic attached to the surface 
by weaker linkages. 
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   FIGURE 1.3 Oligodendrocyte ultrastructure 
A. Electron micrograph of an oligodendrocyte from the spinal cord ventral columns 
of an adult mouse. Note the irregular feature of the nuclear chromatin, the density of 
the cytoplasm due to considerable amount of free ribosomes and microtubules and 
prominent Golgi apparatus (white arrows). Also note the lack of intermediate 
filaments which identifies astrocytes. Nucleus (Nu). 
B.  Oligodendrocytes myelinates axons in the CNS which is clearly seen in this 
micrograph. The oligodendrocyte  processes are ensheating at least five axons (A1-
5). 
      Scale bar A = 1µm, B = 2 µm.                  (Griffiths, unpublished observations) 
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1.4.1.1 Lipids 
 
Myelin (dry mass) has a high ratio lipid to protein in contrast to most biological 
membranes, which have a higher ratio protein to lipids.   Biological membranes are 
formed by lipid molecules, largely phospholipids, consisting of 2 hydrophobic 
hydrocarbon tails and a hydrophilic head group, where the phosphate is located.   Two 
monolayers of lipid molecules with their hydrophobic tails tightly packed are sandwiched 
together tail to tail to form a bilayer.   The membrane is fluid with individual molecules 
able to diffuse laterally, rotate or even “flip-flop” across the layers. 
Different types of cells have a different mixture of lipids in their membranes depending on 
function.   There are three classes of membrane lipid molecules:  
1.   Phospholipids, which spontaneously form bilayers 
2.   Cholesterol, which enhances permeability 
3.   Glycolipids, which are found exclusively in the non-cytoplasmic half of the bilayer 
where they are thought to self associate into microaggregates by forming hydrogen bonds 
with one another.   This asymmetrical distribution also suggests some role in interactions 
of the cell with its surrounding.   The most complex glycolipid, ganglioside, carries a net 
negative charge and might be important for its electrical effect.   Glycolipids may also 
play a role in electrical insulation.    
There are no myelin-specific lipids although galactocerebroside, (GalC), is the most 
typical of myelin constituting 22.7% of myelin lipids (dry mass).   In order of abundance, 
in addition to cerebrosides, the major lipids of myelin are cholesterol, ethanolamine, 
lecithin and sphingomyelin. 
Several myelin specific proteins are amphipathic with lipid bilayer spanning domains and 
as such contribute to the lipid structure of myelin. 
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1.4.1.2  Proteins 
 
The protein composition of CNS myelin is simpler than for other brain membranes with 
proteolipid protein (PLP/DM20) and myelin basic protein (MBP) making up to 60 – 80% 
of the total in most species.   A variety of minor proteins and glycoproteins are also 
present.   With the exception of MBP none of the myelin proteins is easily extractable or 
soluble in aqueous solutions, however, they can be solubilised in sodium dodecyl sulphate 
(SDS) solution.   In this state they can be separated easily using electrophoresis in 
polyacrylamide gels, the so-called SDS-PAGE technique.   Current ideas propose PLP to 
be the major integral protein for stabilizing the intraperiod line and MBP an extrinsic 
protein localized exclusively at the cytoplasmic surface is believed to be the major protein 
for stabilizing the major dense line.   These hypotheses are supported by ultrastructural 
abnormalities observed in inherited dysmyelinating conditions or gene targeting studies.   
For example, the shiverer mouse, which lacks MBP due to a major deletion within the 
Mbp gene (Privat et al, 1979;  Roach et al, 1985) and the Plp1 null mouse (Yool et al, 
2002;  Klugmann et al, 1997), which is deficient in PLP/DM20.    
(a) Myelin Basic Protein (MBP) 
Myelin basic protein constitutes approximately 30 % of the myelin protein in the CNS.   
The primary structure i.e. the amino acid sequence of MBP was established by Eylar et al 
(1971) for bovine brain and Carnegie (1971) in humans (for review see Baumann and 
Pham-Dinh (2001).   There are several spliced variants of MBP, up to seven in mice and 
four in humans ranging from 14 – 21.5 kDa.   The gene structure consists of seven exons 
over a stretch of 32 kb on chromosome 18 in mice and 45 kb in humans on chromosome 
18q22-qter (Baumann et al 2001).   MBP is a hydrophilic, highly unfolded protein with 
virtually no tertiary structure in solution.   MBP is localised on the cytoplasmic interface 
of the oligodendrocyte plasma membrane at the major dense line, which is formed by 
compaction of the oligodendrocyte processes during myelination.   The protein is locally 
incorporated into the myelin sheath by a signal mediated mRNA transport to the periphery 
(Ainger et al, 1993, 1997).   Studies of the shiverer mutant mouse, in which MBP is 
absent, (Roach et al, 1985), provided evidence that  MBP is of major importance for 
formation of the major dense line and myelin compaction. 
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(b) Myelin-Associated Glycoprotein (MAG) 
Myelin-associated glycoprotein is one of the larger myelin membrane proteins but 
represents only 1% of the total protein (dry mass) in the CNS.   MAG consists of 13 exons 
distributed over 16 kb stretch on chromosome 7 in mice and 19 in humans.   The apparent 
molecular mass is 100kDa as established with SDS-PAGE.    Two isoforms of  MAG have 
been identified:  large MAG (L-MAG) and small MAG (S-MAG) 72 and 67 kDA 
respectively in the absence of glycosylation (Frail et al, 1985;  Salzer et al, 1987).   MAG 
is situated periaxonally in the CNS and has one transmembrane, one extracellular and on 
intracellular domain. 
The function of MAG has been elucidated through the use of MAG gene knockout mice 
(Li et al, 1994;  Montag et al, 1994;  Yin et al, 1998).     These MAG deficient mice show 
an abnormal formation of the periaxonal cytoplasmic collar and cytoplasmic organelles 
between lamellae suggesting a blocking or delaying of myelin compaction.   A 
comparatively larger percent of axons in the CNS of knockout mice received myelin 
sheaths than axons in the CNS of WT mice suggesting a role for MAG in helping 
oligodendrocytes distinguish between myelinated and unmyelinated axons.   MAG also 
appears important for the long-term survival of myelinated CNS axons (Pan et al, 2005). 
(c) Cyclic Nucleotide Phosphodiesterase (CNP) 
2',3' Cyclic nucleotide 3' phosphodiesterase belongs to a group called Wolfgram proteins 
after fractionation of myelin was performed by Wolfgram (1966) and thereby identified a 
group of high molecular weight myelin proteins (see Campagnoni, 1988 for review).    
CNP is the major component of the Wolfgram fraction proteins that constitutes 4 % of the 
total myelin with a gene structure of 4 exons over 7kb in man and mouse.   Two isoforms 
are expressed by alternative splicing referred to as CNP1 and CNP2. 
The CNP protein has been localised to photoreceptor cells in the retina and 
oligodendrocyte cytoplasm;  specifically the cytoplasm filled inner- and outer tongue 
processes of non-compact myelin and the paranodal loops at nodes of Ranvier (Trapp et al, 
1988), where they are in close contact to the 2 nm gap apposing the axolemma.   An 
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axon/glial function has been proposed for CNP and evidence to this effect has been shown 
in studies with CNP deficient mice (Lappe-Siefke et al, 2003).     In these mice, compact 
myelin remains normal;  however, axons and inner tounges display organelle rich 
swellings and the axons degenerate with time.   In a study of CNP deficient young 
animals, both inner tongue and axonal organelle filled swellings occur together with 
axonal degeneration and abnormal, excessive “swirls” of myelin in small diameter axons 
(Edgar, personal communication).     Thus not only is CNP a requirement for normal 
development of oligodendrocytes that myelinate small axon but absence of CNP possibly 
also creates a toxic environment for these axons. 
(d) Proteolipid Protein (PLP) and DM20 
The proteolipid protein PLP (with its smaller isoform DM20) is the single most abundant 
protein in CNS myelin.   Proteolipid proteins were discovered by Folch and Lees in 1951 
together with other lipid protein complexes extracted by organic solvent mixtures from 
CNS white matter and retained that name because of its large presence in myelin.   PLP 
constitutes approximately 50% of the myelin proteins in the CNS.   The gene encoding 
PLP has been localised and consists of 7 exons stretching over ~ 17kb.   The isoform 
DM20 is a spliced variant identical to PLP except for exon 3B which is omitted (Nave et 
al, 1987; Griffiths et al, 1998). 
The primary structure of PLP and DM20 has been established by direct sequencing and 
indirectly from cDNA clones to comprise 276 and 241 amino acids respectively.   The 
amino acid sequence of PLP is strongly conserved among mammalian species with human 
and murine PLP being 100% identical (Popot et al, 1991;  Diehl et al, 1986;  Macklin et al, 
1987).     Human and murine PLP also have a 99% homology with protein from dogs and 
cattle (Sobel et al, 1994;  Lees et al, 1983;  Stoffel et al, 1983), a 98% homology with rat 
PLP, even bird and amphibian PLP show a high degree of homology > 85% which points 
to an important role for PLP in myelination. 
PLP is a highly hydrophobic and polytopic transmembrane protein.   Although the exact 
topology of PLP is unknown it is generally accepted that the model developed by Popot et 
al (1991) and confirmed experimentally by Weimbs and Stoffel (1992) is the tertiary 
structure of PLP.   The model predicts alpha-helical transmembrane domains spanning the 
  13   
whole membrane bilayer with two extracytoplasmic and three cytoplasmic domains 
including an amino and a carboxyl terminal (Fig.1.4).   The extracellular loops have been 
identified through immunostaining with cell surface markers i.e.   the O10 antibody (Jung 
et al, 1996;  Thomson et al, 1997).     The cytoplasmic loop has been identified with a PLP 
specific antibody recognising an epitope on residues 116 – 150, which is deleted in DM 20 
(Trifilieff et al, 1985; Nave et al, 1987). 
Numerous functions have been proposed for PLP and DM20 in CNS.   Currently, 
PLP/DM20, together with claudin-11 (also known as oligodendrocyte-specific protein) is 
known to be necessary for the formation of the intraperiod line (Chow et al, 2005;Yool et 
al, 2002;  Boison et al, 1995) and appears necessary for the long-term maintenance of 
small diameter axons (Griffiths et al, 1998).     Other functions, such as a secreted C-
terminal fragment that can influence proliferation of oligodendrocyte progenitors, have 
been proposed (Yamada et al, 1999). 
Surprisingly, the Plp1 null mice assemble large amounts of myelin.   The myelin is 
partially compacted but with intermittently condensed or absent IPL which confirms the 
role for compaction.   Demyelination does not occur.   However, these mice develop an 
axonopathy with axonal swellings and degeneration perhaps indicating a role for PLP in 
glial/axonal interaction (Yool et al, 2002;  Griffiths et al, 1998;  Edgar et al, 2002).     The 
severe dysmyelinated MBP deficient shiverer mice lack similar axonal swellings to PLP 
null mice but they recur in the MBP/PLP-deficient double mutant which further 
substantiates the role of glial/axonal communication (Griffiths et al, 1998). 
Pelizaeus-Merzbacher (PMD) and its allelic disorder spastic paraglegia type 2 (SPG2) are 
heterogeneous disorders in man caused by mutations or dosage alterations of the PLP1 
gene (Al-Saktawi et al, 2003;  Garbern et al, 1999).     Duplication of the PLP1 locus is the 
most frequent cause of PMD/SPG2 with a wide variety of missense mutations the major 
cause of the remaining cases.    
Spontaneous point mutations of the Plp 1 gene occur in a range of animal species where 
the severity of phenotype varies considerably (for review see Nave and Griffiths, 2004).     
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FIGURE 1.4  Modified schematic model  of myelin proteolipid protein (PLP) based on 
the predicted tertiary structure developed by Popot, (1991).   The model predicts 4 α-
helical transmembrane domains spanning the whole membrane bilayer with two 
extracytoplasmic and three cytoplasmic domains including an amino (NH4) and a 
carboxyl terminal (COOH). The PLP protein is acylated at six cysteine residues (shown 
in red) increasing its overall hydrophobicity. The extracellular loops have been 
identified through immunostaining with cell surface markers i.e. the O10 antibody (Jung 
et al, 1996; Thomson, 1997).   The cytoplasmic loop has been identified with a PLP 
specific antibody recognising an epitope on residues 116 – 150, which is deleted in DM 
20 (shown in turquoise) (Trifilieff et al, 1985;  Nave et al, 1987). Anti-PLP226 
antiserum (N.P.   Groome, Oxford Brookes University, Oxford, UK) which recognises 
the carboxy terminus (amino acids 271 to 276) of both PLP and DM20 protein isoforms 
(Fanarraga et al, 1993) was used throughout this thesis.  
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1.4.2  PROTEIN TRAFFICKING 
PLP and DM20 have different expression patterns.   The murine Dm20 transcript occurs as 
early as E 9.5 (embryonic day) (Timsit et al, 1992;  Spassky et al, 1998) and the protein at 
E12 (Dickinson et al, 1996) whereas the Plp transcript occurs at P 0 – 2 (postnatal day) 
coinciding with the onset of myelination.   PLP levels peak at P22 when myelination is 
most active ( Verity and Campagoni, 1988).     Plp and Dm20 message isoforms are 
translated on the rough ER and the proteins progress through the secretory pathway 
through the Golgi apparatus to the plasma membrane where they incorporate into the 
myelin (Gow et al, 1994).     Two post-translational modifications occur.     The amino 
terminal methionine is lost and the proteins undergo acylation, possibly in both the Golgi 
apparatus and the myelin membrane.   The PLP protein is acylated at six cysteine residues 
increasing its overall hydrophobicity.   The DM20 protein is also acylated but lacks two of 
the acylation sites that are present in the intracytoplasmic loop.   Both isoforms are present 
in PNS at lower levels.   In Schwann cells, PLP gene products are localised to the 
perinuclear region (Griffiths et al, 1995).     DM20 is the major isoform and is localised to 
the non-compacted regions of the Schwann cell myelin. 
Both isoforms, PLP and DM20, appear necessary for normal structure and function in the 
CNS. Plp1 null mice, complimented with either PLP or DM20 and mice expressing only 
DM20 all showed CNS defects (Griffiths et al, 1998;  Stecca et al, 2000;  Spörkel et al, 
2002). 
 
1.5 MICROGLIA 
Microglia belong to the second group of cells classified as glia cells.   Controversially they 
were classified as microglia of mesodermal origin by del Rio Hortega and although it is 
generally accepted that microglial progenitors arise from peripheral mesodermal tissue 
their precise origin is still debated today (Chan et al, 2007). They are considered the 
immune cells or resident macrophages of the CNS. Microglia are found throughout the 
entire CNS. They are heterogenously distributed in both grey and white matter and from 
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one region to another (Lawson et al,1990). In rodent brain, microglia account for 4 to 
5.5%, of all cell types in major white matter tracts such as the corpus callosum and optic 
nerve (Lawson et al, 1990; Mori and Leblond,1969; Vaughn and Peters, 1968). In normal 
human white matter, the proportion of cells that are microglia is even greater, at 13% 
(Hayes et al,1987) and in contrast to the rodent, they are more prevalent in white than in 
gray matter (Mittelbronn et al, 2001).  
Microglia have elongated nuclei which are smaller than those of other glial cells, 
averaging 5.1µm in length and 2.2 µm in diameter (Mori and Leblond ,1969). 
Ultrastructurally the nuclei are rich in heterochromatin, similar in appearance to dark 
oligodendrocytes, with  a very thin perimeter of cytoplasm around most of the nucleus. 
However, the two cell types can be differentiated by the convoluted outline of the nuclear 
membrane and the clear space which separates the nucleus from the cytoplasm in 
microglia. Cisterns of endoplasmic reticulum, Golgi stacks and mitochondria are present, 
and dense bodies, including lysosomes and phagosomes, are frequent (Karasek et al, 2004;  
Mori and Leblond ,1969).   Microglia also contain filamentous actin and a few 
microtubules, but glial filaments and glycogen granules, which are prominent in 
astrocytes, are absent (Mori and Leblond, 1969).  
The morphology of microglia changes in response to CNS injury and neurodegenerative 
disease as the cells acquire an ‘activated’ phenotype. These ‘activated’ microglia have 
larger cell bodies and thicker and shorter processes than the ramified microglia of the 
healthy brain and are usually found in increased numbers (Perry et al, 2007;  Ip et al. 2006;  
Lawson et al, 1994; . Perry et al, 1994;  Zhang et al, 2001).  Microglia are influenced by 
systemic infection or inflammation  (Perry et al, 2007) and can be seen filled with 
phagocytosed material and engulfing dying CNS cells (Streit et al, 2002). 
 
1.6 EPENDYMAL  CELLS 
Ependymal cells are the third class of glia cell, identified by Purkinje in 1836 who 
described a ciliated epithelium lining the cerebral ventricles (see Pannese 1994).  
Ependymal cells are, flattened, cuboidal or columnar spongioblasts, of ectodermal origin. 
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During embryonic development they proliferate, overlying the neural tube assisting the 
formation of an external limiting membrane.   After neural folding, the ependymal cells 
are restricted to lining the ventricular system including the spinal central canal or form 
part of choroid plexus.   Mature ependymal cells are proposed to be involved with 
secretion, absorption, transport, receptor as well as a barrier function between 
cerebrospinal fluid/blood and brain (Berry et al 2003). Morphologically the cells differ 
depending on region but all have an indented nucleus with cytoplasm rich in mitochondria, 
lysosomes, microtubules and microfilaments (Brightman and Palay 1963;  Berry et al, 
2003) and are of varying length, 0.2 µm – 15 µm in mammals (Westergaard, 1970).  
Ependyma does not regenerate and hence injury to the ventricular lining has serious 
consequences resulting in discontinuity of the neuropil and reactive gliosis by 
subventricular astrocytes (Pekny and Nilsson, 2005).   Recently, the subventricular zone 
beneath the ependymal lining is the subject of growing interest due to the fact that it is a 
neurogenic region containing neural stem cells (Nait-Oumesmar et al, 2008).   These stem 
cells are thought to be of astrocytic origin and generate migratory neurons.   
Subventricular zone astrocytes have also been detected in active repair of the ependyma in 
geriatric animals, with electron micrographical evidence of astrocytes gaining epenymal 
cell like cilia (Romanko et al, 2004). 
 
1.7   ULTRASTRUCTURE 
The first electron microscope was built in the 1930s by a German company Knoll and 
Ruska (Ham, 1974) and commercially available EMs appeared later in that decade.   
However, it was not until the mid 1960s after numerous problems such as sectioning, 
fixation, embedding medium  were sufficiently resolved by renowned scientists 
(Fernandez-Moran, Sjostrand, Sabatini, Glauert, Afzelius are but a few of the pivotal 
individuals) that biological ultrastructural research began in earnest. 
The ultrastructure of biological tissue are components of cells only visible beyond the light 
microscopy level i.e.   electron microscopy, where magnifications of 500 to 1,000,000 
times are possible.   The resolving power, i.e.   the distance at which 2 points can be 
  18   
distinguished, of the electron microscope is 0.2 nm or even sub-Ångstrom levels in high 
resolution EM as opposed to LM which is 0.2 µm.   Although some subcellular features 
can be seen at light microscopy level through staining,  eg.   Nissl substance in neurones, 
what is seen is the stain not the feature itself.   In the EM it is clear that Nissl substance 
consists of aggregates of rough ER with numerous ribosomes each distinguishable, both 
attached and scattered in between the flattened cisternae. 
EM studies used to be restricted to purely morphological investigations.   Although 
biochemical investigation using EM techniques were at its height in the 1970s and 1980s, 
speciality skills and equipment needed made this a very narrow research field.    
Preparation of tissue and subsequent staining protocols, time, cost and methods available, 
served to make EM studies increasingly unpopular.   However interest was resumed 
during the late 1990s when molecular biology and immunohistochemical investigations 
needed sub-cellular levels of resolution.   Methods for EM developed progressively and 
are still evolving. 
1.7.1   ULTRASTRUCTURAL ANATOMY OF MYELINATED FIBRES 
1.7.1.1   Axon 
The ultrastructure of axons is well defined (see Peters et.al, 1976).   Although the axon and 
its hillock is an extension of the nerve cell, it lacks the Nissl substance that characterises 
the perikarya and dendrites, which are easily identified even at LM level through 
basophilic staining.   At EM level, the axolemma, the plasma membrane of the axon is a 
trilaminar feature 7-8 nm in thickness and distinct.   The cytoplasm of the axon contains 
neurofilaments, microtubules, mitochondria, agranular ER (axoplasmic reticulum), 
vesicles and multivesicular bodies but lacks Golgi apparatus, rough ER and most other 
components which are involved in protein synthesis. 
Neurofilaments (nf) are a prominent feature of axons which are also present in perikarya 
and dendrites.   On entering both axons and dendrites, neurofilaments converge and align 
themselves parallel to the length of the processes.   Fernandez-Moran and Dahl (1952) 
were first to describe and classify these structures.   They were later found to be tubes 
rather than rods measuring 90-100Ẳ in diameter (Peters et al, 1976 for review). 
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Microtubules also known as neurotubules are also tubular, slightly larger than 
neurofilaments, measuring 200-250Ẳ.   While neurofilaments predominate in large axons, 
the proportions of neurofilament and mitochondria are progressively reversed with the 
decrease of axon diameter so that mitochondria predominate within small axons (~0.1µm 
or less in diameter). 
1.7.1.2   Myelin 
Ultrastructurally, myelin is a spiral encasement of the axon where the oligodendrocyte 
cytoplasm is squeezed out during compaction of the membranes.   Thus, the characteristic 
periodic structure of alternating concentric electron-dense and electron-light layers is 
formed.   The major dense line consists of a fusion between the two apposing intracellular 
membranes and the minor, light, intraperiod line consists of a close apposition of the 
apposing extracellular membranes of the spiralling oligodendrocyte process.   An inner 
and outer tongue, each running longitudinally along the entire myelin sheet can be seen in 
cross sections as loops containing cytoplasm (Fig.1.5).   In longitudinal section at the node 
of Ranvier paranodal terminal loops similarly containing cytoplasm are present (Fig.1.6).   
Transverse bands, which are septate-like junctions and connect the myelin sheath to the 
axolemma can be seen in the 2nm gap at the paranodal loops (Rosenbluth, 1999;  Scherer 
et al, 2004;  Hirano and Dembitzer, 1982). 
1.7.2 ULTRASTRUCTURAL IMMUNOHISTOCHEMICAL 
TECHNIQUES 
There are now several techniques available for immunohistochemical procedures at EM 
level.   The most published are immunolabelling techniques such as immunogold, 
peroxidase-anti-peroxidase (PAP), ultracryostat techniques and to a lesser extent the 
photo-oxidation technique.   There are disadvantages with all of them and the investigator 
has to evaluate the criteria that are of most importance to them. 
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FIGURE 1.5  Transverse sections of myelinated axons from the spinal cord ventral 
columns of an adult mouse. Note the characteristic periodic structure of alternating 
concentric electron-dense and electron-light layers of the myelin sheath. 
A. The inner tongue (black asterisk) and the outer tongue (white asterisk) of the myelin 
sheath can be seen as loops containing oligodendrocyte cytoplasm. A periaxonal space 
(pa) is maintained between the oligodendrocyte and the axon (Ax) throughout their 
apposed positions with specialisations occurring at the paranodal loops only. The 
cytoskeletal features within the axon consists of microtubules (mt) and neurofilaments 
(nf). 
B. High magnification of the compact myelin sheath showing the major dense lines 
(Mdl) formed by fusion between the two apposing intracellular membranes and the 
minor light intraperiod line (Ipl) formed by close apposition of the extracellular 
membranes during the ensheathment of the axon. 
Scale bars A = 250 nm, B = 50 nm.  (Griffiths, unpublished observations) 
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FIGURE 1.6 Electron micrograph of a longitudinally sectioned myelinated 
axon from the optic nerve of an adult mouse. 
A.  A node of Ranvier (node) occupies the nerve in the centre of the picture 
where astrocyte processes ( black star) can be seen adjoining the unmyelinated 
part of the axon. On either side of the node, paranodes (paranode) with their 
terminal loops (white asterisk) containing oligodentrocyte cytoplasm are 
present. Internodes runs in between paranodes and can be seen in this picture 
on the right hand side labelled (internode). 
B.  Part of a paranode showing cytoplasmic loops (black asterisk). Transverse 
bands (Tb) which are septate-like junctions can be seen in the gap between the 
myelin sheath and the axolemma. 
Scale bars A = 2µm, B = 50nm.        (Griffiths, unpublished observations) 
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1.7.2.1   Immunogold  
Immunocytochemistry and EM have been combined since the 1950s.     In their review, 
Afzelius and Maunsbach (2004) highlight Singer, in 1959, who introduced ferritin as an 
electron-dense antibody tracer and later Faulk and Taylor (1971) who developed gold 
particles for immunolocalisation purposes at the EM level.   These techniques are still used 
today.    The indirect labelling technique, that is most commonly used today, consists of 
introducing a tagged secondary antibody against an untagged primary antibody.   This 
two-layer technique was pioneered by Baxandall et al (1962).     Although elegant results 
are generated, it is notoriously difficult to get consistent and reliable results with this 
method because of the many steps involved.   Fixation is certainly an issue and a 
compromise between preservation of the tissue and preservation of antigenicity will often 
have to be reached.   There is also an issue whether a quantification of labelling is 
possible.   Last but not least the processing and embedding of specimens are of 
considerable concern.   Standard resins like Durcupan™ and even Araldite™ have been 
used with some success on brain tissue (Maxwell et al, 1995;  Maxwell and Riddell, 
1999).     However specialist resins for immuno-EM are now available i.e LowiCryl™, 
LRWhite™ and LRGold™ (Scherer et al, 1995;  Tait et al, 2000).     The negative aspect 
in the use of these resins is the requirement for special equipment to either cure or cut the 
embedded tissue. 
Investigations of myelin proteins using the immunogold have been explored but with 
limited success.   Most publications on this subject use immunogold in combination with 
the ultracryo technique (Trapp et al, 1989;  McLaurin et al, 1993;  Sobel 1994;  Yin et al, 
1998, 2006). 
1.7.2.2   PAP and ABC 
Peroxidase-antiperoxidase (PAP) and avidin-biotinylated enzyme complex (ABC) are 
similar peroxidase activity labelled immunological techniques.   The latter, an intensified 
labelling version of PAP was introduced by Hsu et al (1981a, b).     These indirect labeling 
techniques employ a secondary antibody linked to a peroxidaxe complex which forms a 
reaction product that is revealed with a chromogen.   Usual chromogens are 
diaminobenzidine derivatives.   The reaction product can be enhanced with heavy metals 
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i.e nickel, cobalt and more commonly osmium.   The techniques are used successfully for 
light microscopy but have a limited use for electron microscopy mainly because the 
reaction product tend to be shallow and diffuse, situated away from the reaction site.   
Publications using these techniques on the CNS were most prolific in the 1980 and1990s 
(see Deerinck et al, 1997;  Sekirnjak et al, 1997;  McMahon et al, 2000 as elegant 
illustrative examples). 
1.7.2.3   Ultracryosectioning 
Ultracryosectioning is a technique introduced by Tokuyasu in 1973 and involves infusing 
fresh or fixed tissue with polyvinalpyrrolidone (PVP), directly fitted onto stubs followed 
by rapid freezing  in low temperatures approx  -187 C. The tissue is then sectioned in an 
ultracryomicrotome, picked up onto copper mesh grids, embedded in resin and stained for 
viewing in an EM.   It is perhaps more widely used now but is still a very difficult 
technique.   Not only is it difficult to orientate the tissue during freezing and identify areas 
of interest after freezing, but the need to embed the tissue when it is situated on the grid in 
contrast to conventional EM techniques where sectioning takes place after embedding, 
makes this a technique suitable only for people with considerable experience.   To couple 
this technique with immunogold labelling and its disadvantages makes this method 
capricious and time-consuming.    
1.7.2.4   Photo-Oxidation 
Fluorescence photo-oxidation with eosin is a high resolution immuno-localisation method 
(Deerinck et.al, 1994).     Eosin, a fluorescent marker, conjugated onto a secondary 
antibody is excited in a fluorescence microscope (FM) by UV light in the presence of 
diaminobenzidine tetrahydrochloride (DAB).   DAB is oxidized and an osmiophilic 
reaction product is formed.   The advantage with this method is that the reaction product is 
highly insoluble making it easily visible by LM.   Since it is osmiophilic, enhancement 
with osmium tetroxide (OsO4) makes it visible by EM.   A further advantage is that the 
same tissue can be viewed by all three options e.g.   a specific fluorescing site can be 
identified by FM, photo-oxidized and verified by LM, processed for EM while orientation 
of the oxidized site is visibly aligned. 
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Eosin or eosin-5- isothiocyanate (EITC) is a brominated derivative of fluorescein.   It is 
essentially identical but has 4 bromine atoms added, which significantly increases the non-
fluorescent dissipation of energy from the excited dye molecule, which in turn increases 
the generation of singlet oxygen molecules (
1O2 ). 
Fluorescein and rhodamine are commonly used for immunolabelling because of their high 
fluorescence quantum yields, but they yield low quantities of singlet oxygen, which makes 
them less suitable for photo-oxidation.   Even with intense immunolabelling Deerinck’s 
group found it difficult to detect staining using FITC and rhodamine in the EM.   EITC has 
a singlet oxygen quantum yield approximately 19 times greater than FITC and it still has a 
moderate fluorescence property, although it is only ~ 20 % as bright as fluorescein. 
Because EITC is a small molecule penetration of labelling reagents is high, hence 
specificity is optimised and very different from e.g. avidin-biotin complexes  and colloidal 
gold conjugates (Hsu et al, 1981; Sternberger, 1986). This method therefore appears to be 
suitable for the detection of the membrane bound myelin proteins PLP and DM20. 
 
1.8   AIM OF STUDY 
The aim of this study was to critically evaluate sub-cellular localisation techniques for the 
purpose of studying the biology of proteolipid proteins in myelin.    
Ultrastructural techniques will provide the best resolution to establish the sub-cellular 
localisation of the two myelin protein isoforms encoded by the Plp1 gene in mice and 
from these data postulate functions for the two isoforms.   The Plp1 gene encodes the two 
proteins DM20 and PLP.   The gene is expressed primarily by oligodendroglia of the 
central nervous system (CNS), with some expression (primarily of DM20) in the Schwann 
cells of the peripheral nervous system.   In the CNS, the DM20 isoform is expressed both 
prior to and during myelin initiation and maintenance.   It is of unknown function.   The 
expression of the PLP isoform appears to be related to myelination and has a structural 
role in compact myelin.   An objective was to establish an immunolocalisation technique 
which would allow the hypothesis to be tested that DM20 is expressed in non-compacted 
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regions of the oligodendrocyte (premyelinating, ensheathing and myelinating) as well as 
compact myelin, whilst PLP expression is confined to the compact myelin sheath.    
The EM techniques most suitable for immunolocalisation of the PLP isoforms are 
immunogold and fluorescence photo-oxidation with eosin.   Immunogold labelling of 
myelin proteins (Arvanitis et al, 1992, Trapp et al, 2006) has traditionally been used but 
the immunogold technique is renowned for being difficult and morphological resolution 
may be impaired due to the inaccessibility of the targeted PLP epitopes.   Fluorescence 
photo-oxidation with eosin in the presence of diaminobenzidine tetrahydrochloride 
provides a high-resolution depiction of sub-cellular antigen distribution (Deerinck et al, 
1994) and may be more suitable.   Antibodies for this study are already well established 
and used in our laboratory.   The PLP226 antibody recognises the C-terminal of both PLP 
and DM20.   PLP A antibody recognises the exon specific to PLP only.   Differential 
immunolabelling may allow us to determine the sub-cellular location of the two protein 
isoforms on separate sections.   Both antibodies are recognised by a goat-anti-rabbit IgG 
secondary antibody to which the eosin fluorophore for the photo- oxidation method or 
colloidal gold for immunogold method will be conjugated.     
Myelin is a notoriously difficult membranous structure to study morphologically due to its 
high lipid content interspersed with protein. Lipids are difficult to preserve without 
undesirable extraction during processing resulting in distortion and membranes are 
difficult to penetrate without physical damage.     It was recognised at the outset that this 
study would be difficult due to the criteria deemed necessary, i.e.   firstly the structure of 
tissue should be preserved and secondly there should be a differential labelling of myelin 
to non-myelin tissue suitable for statistical analysis. 
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CHAPTER 2     MATERIALS AND METHODS 
 
2.1 GENERAL TISSUE PREPARATION 
2.1.1 TISSUE SOURCE 
The wild type mice were an inbred hybrid C3H/101 strain, which were bred in house for 
over 15 years.   The Plp1 null mice were derived by gene targeting using Sv129 
embryonic stem cells in C57BL/6 mice with subsequent generations being bred on the 
C57BL/6 background (Klugmann et al, 1997). 
2.1.2   FIXATION 
Transcardiac perfusion fixation was performed in a fume cupboard according to COSHH 
regulations.   General solutions are detailed in Appendix 5.1. 
Wild type and Plp1 null mice were humanely euthanased using an overdose of carbon 
dioxide or halothane in a closed chamber.  Perfusion took place through a thoracotomy.   
The right atrium was nicked to ensure flow of the perfusate.   Depending on the size of the 
animal, a 21-23 gauge hypodermic needle was introduced into the left ventricle.   
Perfusion was initiated with a flushing of ~10 ml PBS (see appendix 5.1.1)using a 
perfusion circuit consisting of two 20 ml syringes (one for PBS and one for fixative) 
attached to a three way tap connected to a line leading to the hypodermic needle.   The 
initial flushing with PBS to clear blood from the circulatory system was followed by 
perfusion with 20-40 ml fixative.  Composition of the fixative varied depending on 
specific procedures.    
 2.1.3 DISSECTION 
Following perfusion,  animals were wholly immersed in fixative 1-24 hours prior to 
dissection.   Dissection was carried out under a low power dissection microscope and 
fixative fumes extracted via a fume extractor. 
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The top of the cranium was removed to expose the brain.   The meninges were severed and 
the whole brain carefully extricated using microsurgical instruments.   When needed, the 
optical nerves were removed still attached to the optic chiasm.   The orbits were also left 
attached to allow orientation after disconnection to the brain.   The cervical part of the 
spinal cord was similarly extricated and stripped of meninges after severing the nerve 
roots.    
2.1.4 CELL CULTURE 
Oligodendroglial cultures were established and grown by Anne Hunter Appl. 
Neurobiology Group (see Thomson et al, 1999). 
Cells were grown for 5-7 days in vitro before being stained for both PLP/DM20 (using the 
226 antibody) or PLP only (using PLPA antibody). The stained cells were visualised by 
fluorescence microscopy. 
2.1.4.1 Staining protocol 
The staining protocol was performed on a staining platform consisting of Eppendorf™ 
caps glued onto an inverted lid of a tissue culture dish, thus, able to hold individual 
coverslips.   To prevent coverslips drying out overnight, the bottom of the inverted lid was 
moistened with water and the base tray of the culture dish used as cover.   All steps except 
for the primary antibody application were carried out at room temperature.  
Oligodendrocyte cultures were fixed in 4% paraformaldehyde, 0.1% glutaraldehyde/PBS 
for 10-15 min.   After 3x10 minutes washes in PBS the cell membranes were 
permeabilised in 0.5% or 0.1% Triton X-100 for 30-60 minutes.   To block non specific 
antibody staining, the coverslips were immersed in DV blocking buffer (see appendix 
5.1.3) for for 30-60 minute.   Coverslips were drained and incubated with a primary 
antibody, PLP 226 IgG fraction diluted in DV buffer 1:50,  overnight at 4° C.  A wash in 
PBS, 3x10 minutes, was followed by incubation in the secondary antibody, either EITC 
diluted as necessary or FITC diluted at 1:80.   A further wash in PBS, 3x10 min, was 
followed by nuclear staining with 4, 6-diamidino-2-phenyl-indole (DAPI, Sigma)/PBS 
diluted to 1:1000 for 1 min.   A short wash in distilled water was performed prior to 
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mounting the coverslips onto glass slides in either Citifluor mounting media or PBS. The 
edges of the coverslips were sealed with nail varnish. Stained cells were kept on slide 
trays, covered with aluminium foil at 4°C. 
2.1.5 CRYOSTAT SECTIONS 
Frozen tissue sections were used to establish the titre for the conjugate EITC.   Controls 
were always included; the positive where the EITC conjugate was substituted for a FITC 
conjugate and the negative where no primary antibody was applied.   Animals were 
perfused as described in 2.1.2.   The whole brain was dissected out as described in 2.1.3, 
thereafter immersed in a 20% sucrose solution.   Freezing took place by dropping the brain 
into isopentane (-56°C) chilled with liquid N2.   Frozen tissue was stored in a freezer at            
-20°C.     
Sections were cut on a Bright cryostat at a thickness of 10 – 15 µm.    
2.1.6 ANTIBODIES 
For all methods, well-established primary antibodies routinely used in our laboratory were 
applied.   Anti-PLP226 antiserum (N.P.   Groome, Oxford Brookes University, Oxford, 
UK) raised in rabbit, which recognises the carboxy terminus (amino acids 271 to 276) of 
both PLP and DM20 protein isoforms (Fanarraga et al, 1993).     A rabbit polyclonal 
antibody specifically created to recognise an epitope in exon 3B (amino acids 117-129), 
solely expressed by the PLP isoform (PLPA)  (E.Trifilieff, University of Strasbourg, 
Strasbourg,
 France).was used.   A rat monoclonal antibody, AA3, (S Pfeiffer, University of 
Connecticut, USA) was also used to recognise the C-terminal of PLP and DM20.   As a 
positive control, a polyclonal astrocyte specific marker recognising glial fibrillary acidic 
protein (GFAP) from DAKO and an anti-myelin basic protein (MBP) polyclonal antibody 
(Chemicon) were also used.   Negative controls were created by omitting primary 
antibodies. 
Secondary antibodies used were specific for each method and are described in the 
appropriate section of this thesis. 
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2.1.7 EM PREPARATION 
Cerebellum and cervical cords were used, mainly.   The cerebellum was halved with a 
razor blade following on from the mid line of the longitudinal fissure of the cerebrum.   1 
mm sagittal slices were removed from the cerebellum and divided into 4 pieces.   1- 2 mm 
and 2-4 mm transverse slices of cervical cord were taken and either left whole or halved 
along the median fissure through the central canal dorsal to ventral and then quartered 
laterally through the central canal, if required.   The slices were embedded and orientated 
for either transverse or longitudinal sectioning. 
Processing for electron microscopic study was carried out in a routine fashion in an 
automatic, programmable Lynx Processor ™ (Leica).   Tissues were loaded into plastic 
mesh baskets, lids fitted and threaded on to a metal arm assembly used to suspend the 
tissues in vial for automatic processing.   Vials contain up to 20ml of liquid.   Agitation 
and temperature adjustment was applied.   A temperature of 4°C was applied for initial 
rinse and secondary fixation.   Room temperature was used for dehydration and initial 
resin infiltration and 30°C applied to final full resin.   The routine processing programme 
is as follows: 
 
 
 
1  isotonic cacodylate buffer  50 min  
2  1% OsO4 in cacodylate buffer  2hr   
3  isotonic cacodylate buffer  30 min  
4 50%  ethanol  5  min  
5 50%  ethanol  10  min  
6 70%  ethanol  5  min  
7 70%  ethanol  10  min  
8 80%  ethanol  5  min  
9 80%  ethanol  10  min  
10 90%  ethanol  5  min  
11 90%  ethanol  10  min  
12 ethanol  20  min  
13 ethanol  20  min  
14 propylene  oxide  15  min  
15 propylene  oxide  15  min  
16a  1:2 resin: propylene oxide  13 hr   
16b  1:1 resin: propylene oxide  6 hr   
17  2:1 resin: propylene oxide  18 hr   
18 resin  4  hr   
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After infiltration, tissues were embedded in resin (see appendix 5.1.5).   For blocking out 
the tissues were orientated in resin-filled silicon moulds and placed in an oven at 60˚C for 
a minimum of 24 hours to polymerise. 
Microscopy sections were first cut on glass knives as semi-thin sections, collected with a 
glass rod and floated out on a water droplet placed on microscope glass slides.   They were 
then dried and stained with 1% azure II and 1% methylene blue in 1% borax (see appendix 
5.1.6) on an 80°C hotplate for light microscopy.   Thin sections were then cut with a 
Diatome™ diamond knife on a Reichert Ultracut E™ at a thickness of 70 – 80nm, floated 
out on water and collected on 200 and 300 mesh copper grids and air dried.   They were 
stained by placing them on droplets in a closed Petri dish lined with Nescofilm™ first with 
a saturated solution of uranyl acetate in 50% ethanol for 10 min, washed by ~10 dips in 
100ml 50% ethanol and 2 x 100ml washes with 10 dips each in dH2O.   Secondly, they 
were contrast stained with lead citrate (see appendix 5.1.7) for 10 minutes similarly placed 
on droplets on Nescofilm but with an added filter paper moistened with 1% sodium 
hydroxide (NaOH) on the bottom of the Petri dish to absorb oxygen which reacts with the 
lead citrate to form a precipitate that can be picked up on the sections.   This was followed 
by 3 washes consisting of 10 dips each in 100ml NaOH (0.01%) and 2x100ml dH2O, 
blotted on filter paper and left to air dry. 
2.1.8 GENERAL IMAGING 
2.1.8.1 Fluorescence Microscopy 
Microscopy sections, cultured cells and photo-oxidation preparations were examined using 
an inverted Olympus IX70 research microscope with 100x 1.25NA oil, 60x 1.4NA, 40x 
0.40NA objective lenses.   Images were captured using Image Pro® Plus 6 software 
(MediaCybernetics). 
FITC absorbs light at a wavelength of 495nm and emits it at 525nm, which can be 
visualised as green light using a blue filter.   DAPI provides a fluorescent light with 
excitation of 345 nm and emission of 455nm.   Excitation wavelength for EITC is 526nm 
and emission is 545nm.   A triple cube allowing visualisation of all 3 fluorophores, as well 
as individual filters, was used. 
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2.1.8.2 Electron Microscopy 
Sections were examined in a JEM CX-100 II transmission electron microscope.   
Photographs were taken on Kodak 4469 cut plate films.   Films were developed 10 min in 
Universal™ developer diluted 1:10.   Developing was stopped in a waterbath with a few 
drops of acetic acid added and fixed for 10minutes in Ilford Hypam™ fixer diluted 1:10.   
Films were then washed in running water for 20 minutes and left to air-dry. 
2.1.8.3 Image capture 
Negatives were scanned (Epson Perfection) into a PC using Photoshop CS2 (Adobe) 
software. 
 
2.2 PHOTO-OXIDATION 
2.2.1 ANIMAL SOURCE AND TISSUE PREPARATION  
In total, 11 wild type mice (see section 2.1.1) were used.   Ages ranged from P17 to P180.   
In total, 30 photo-oxidation experiments were performed (see section 2.2.3.2).   For every 
experiment 4- 8 vibratome sections were used.   Vibratome sections were trimmed and cut 
into 4 segments suitable for EM.   Approximately 5-10 grids were cut from each segment 
(see section 2.2.4). 
2.2.1.1 Fixation 
ESTABLISHING FIXATIVE 
The fixative for the photo-oxidation protocol was established to ensure the maximum level 
of morphological preservation without compromising antigenicity.   Glutaraldehyde cross-
links different regions of proteins and may hide or destroy epitopes.   Therefore, a 
compromise to preserve antigenicity as well as keeping a reasonable morphological 
preservation had to be reached.    
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ANIMAL SOURCE  
Three, P180, wild type female mice were used (see section 2.1.1).   Perfusion was carried 
out as described in section 2.1.2. 
PERFUSION FIXATIVE 
To optimise the photo-oxidation protocol the animals were perfused with different 
fixatives, i.e.: 
1. 4% paraformaldehyde/0.1 % glutaraldehyde/0.1 M sodium cacodylate  
buffer pH 7.2 
2. 4% paraformaldehyde/0.5% glutaraldehyde/0.1 M sodium cacodylate buffer pH 7.2 
3. 4% paraformaldehyde/1% glutaraldehyde/0.1 M sodium cacodylate buffer pH7.2 
Transverse cervical spinal cord sections were dissected from each animal and processed 
and cut using routine EM protocol see section 2.1.7 and section 2.1.8. 
A control mouse of same strain and age was added from the Applied Neurobiology Group 
existing archive of routine strong fixed (5% glutaraldehyde) embedded tissue.   Tissues are 
routinely perfused with a modified version of Karnovsky’s fixative (see appendix 5.1.2) 
and left in fixative at 4°C for at least 2 hrs, but most often overnight.  
2.2.1.2 Vibratome sectioning 
Vibratome sections were cut on a 1000 Plus® (Vibratome).   Whole cerebellum and spinal 
cord were dissected out and mounted directly onto the Vibratome metal trough using a 
small spot of superglue.   The tissue was aligned so that sagittal sections of cerebellum and 
transverse sections of cervical cord would be produced.   The trough was flooded with 
PBS so that the mounted tissue was completely submerged.   Sections were cut at a 
thickness of 50-100µm, cutting speed was 3-5mm/sec.   Sections were picked up with a 
fine tipped paintbrush and transferred to a 5ml Petri dish filled with PBS. 
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2.2.2 IMMUNOHISTOCHEMISTRY 
2.2.2.1 Primary antibody concentration 
Four primary antibodies were used for photo-oxidation experiments.   PLP226, dilution 
1:600; GFAP, dilution 1:1000; MBP, dilution 1:500 and AA3, dilution 1:300.   Negative 
controls were always included (see section 2.1.6). 
2.2.2.2 Secondary antibodies concentration 
CONJUGATION OF EOSIN 
For the photo-oxidation method a conjugated secondary antibody was created with the 
help of Douglas Kirkham (Applied Neurobiology Group) as follows: 
Conjugation of the fluorophore eosin via its 5-isothiocyanate moiety to goat-anti-rabbit 
IgG was carried out using FluoReporter Eosin Protein Labelling Kit ® F-1023 and 
protocol (Molecular Probes Europe BV).   Two conjugations using goat-anti-rabbit IgG, 
(Sigma-Aldrich), was carried out.   One conjugation using goat-anti-rat IgG, (Sigma-
Aldrich), was carried out. 
The conjugation protocol was initiated by adding eosin 5-isothiocyanate (EITC) to a 
reaction tube with goat-anti-rabbit IgG or goat-anti-rat IgG in a 1M bicarbonate solution, 
pH 9.0.   The reaction was stirred at room temperature for 1 hour whilst being protected 
from light and then stopped by the addition of hydroxylamine.   The solution was stirred 
for a further 30 minutes at room temperature.   The conjugate was separated from 
unreacted dye by loading the sample into spin columns, containing 30,000 MW size 
exclusion resin.   After allowing the solution to be absorbed into the gel it was then spun 
on a Heraeus Instruments Labofuge 400 R centrifuge at 1100 x g.   The requirement for 
further purification was assayed by dialysis using a Pierce Slide-A Lyzer Dialysis 
Cassette® with a molecular weight cut off (MWCO) of 10 kDa and dialysed against 0.1 M 
PBS at 4°C.   A single fluorescence staining on oligodendrocyte cultures was performed to 
establish if purification was necessary. 
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Degree of labelling was determined by measuring the absorbance at a wavelength of 
524nm (A542 )  in an Ultrospec III/ Pharmacia spectrometer and using calculation formulas 
as provided in the labelling kit. 
SDS-PAGE 
A sodium dodecyl sulfate polyacrylamide gel electrophoresis was carried out to establish 
that the conjugations of EITC to the IgG were successful.   It was also a useful tool to 
compare EITC against FITC.   The assays were carried out by Dr Mark McLaughlan. A 
12.5 % acrylamide gel  was prepared (see appendix 5.2.2) on a PAGE gel rig (ATTO 
Corporation).  
Samples were prepared in SDS/DTT (see appendix 5.2.2) and denatured by boiling 90º C 
for 4 minutes. Samples were loaded onto the gel as follows: 
First a neat sample of EITC then 3 dilutions each of EITC and FITC i.e.   1:10, 1:20 and 
1:100. A final lane was loaded with a molecular weight marker (Biorad). The gel was run 
in 1X SDS-PAGE running buffer (see appendix 5.2.2) at a constant 100 V. On completion 
the gel was transferred to a UV transilluminator (Herolab) to visualise and record the 
fluorescent bands with a photographic printer (Sony). 
ESTABLISHING TITRES 
 
Titres for goat-anti-rabbit EITC were established using both primary cultured cells and 
cryosections.   Initially, 5 dissociated oligodendrocyte cultures between 5 and 7 days in 
vitro were used followed by 1 explant olidodendrocyte culture, 21 days in vitro.   Finally, 
tissue was tested from a P20 wild type mouse.   Evaluation of titres on sections was 
performed on 10 µm thick cryostat sections of sagittal mouse cerebellum (perfused tissue).   
Initially, ologodendrocyte cultures stained with EITC at  dilutions of 1:10, 1:50, 1:75, 
1:100 and 1:250.   To establish a titre for tissue, cryostat sections were incubated with 
EITC at dilutions of 1:50, 1:75, 1:85 and 1:100.   Staining protocol was carried out as 
described in section 2.1.4. 
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2.2.3 PHOTO-OXIDATION PROTOCOL 
2.2.3.1 Materials 
Photooxidation was performed on a fluorescence microscope (see section 2.1.8).     An 
extraction fan was used in the microscope room to eliminate DAB vapour.   Gloves, mask, 
goggles and protective clothing were used according to COSHH regulation.   The 
microscope and surrounding area was dressed in polythene sheets to avoid any splashes of 
DAB.   The stage was chilled with ice packs to reduce the oxidising rate of DAB.   The 
sections were irradiated using a 100W mercury burner light source and a triple cube with 
an excitation spectrum 490-510. EITC IgG conjugate exhibits an absorption maxima at 
526nm and an emission maxima at 545 nm.  A solution of chilled (~4°C) 2.8 M DAB in 
0.1M sodium cacodylate buffer (see appendix 5.1.4) was constantly suffused with pure 
oxygen to keep the DAB from oxidising.   The solution was kept in a fume cupboard and 
transferred to the microscope in small amounts, packed in ice and administered drop wise 
over the section.   Specialised glass “bottomed” plastic tissue culture Petri dishes (MatTek 
Inc) were used. These tissue culture dishes provide a high resolution microscopic image.     
2.2.3.2 Photo-oxidation 
Vibratome sections were processed in glass Petri dishes and manipulated with a fine 
tipped paintbrush.   Buffer used throughout the protocol was 0.1M sodium cacodylate, pH 
7.4, unless otherwise stated. 
Initially sections were washed in buffer for 30 minutes in three baths.   They were then 
permeabilised in buffered 0.1% Triton X-100 for 30 minutes before blocking of non-
specific IgG binding to reduce background staining.   Blocking buffer consisted of photo-
oxidation buffer (see section 5.2.1) and incubation was 45 minutes.   The sections were 
then incubated in primary antibody, either PLP226, dilution 1:600 or GFAP, dilution 
1:1000, overnight but minimum of 12 hours in a 4°C fridge.   A further three washes in 
buffer took place before the sections were incubated for an additional hour in goat anti-
rabbit IgG-eosin conjugate at room temperature.   Two more washes of 10 minutes each, 
followed by 15 minutes fixation in 2% glutaraldehyde (EM grade) diluted in buffer at 4°C 
the 4°C.   After five washes of three minutes each the sections were treated with 100mM 
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glycine and 50mM aminotriazole in buffer to reduce non-specific staining.   The sections 
were then transferred to the glass “bottomed” plastic Petri dishes, that had been pre-treated 
with 0.1% polyethyleneamine (see appendix 5.2.3). The pre-treatment is important to keep 
the vibratome sections flat and adhered to the base during photo-oxidation.    The dish was 
filled with buffer; the sections transferred and gently pushed down to adhere to the base 
with a paintbrush.   The buffer was sucked out taking care to keep the sections in place and 
refilled very gently.   Next, photo-oxidation took place in a microscope prepared as 
described above.   The Petri dishes containing sections were placed on the chilled 
microscope stage and held in place with tape.   A line with a 10 ml syringe attached was 
also taped to sit inside the Petri dish and provide the means of extracting excess fluid.   An 
irradiation site was identified through the x40 objective lens using transmitted light and 
commenced by changing to a x60 objective lens, introducing the triple cube before adding 
the DAB solution drop by drop.   Photo-oxidation took place during continuous 
observations to establish a visual image of a brown spot where the higher lens created a 
field limit easily observed in the larger field of the lower magnification lens with darker 
brown reaction product appearing (see Fig 3.4 and 3.5a, b). 
2.2.3.3 Propidium iodide 
To check that the protocol was working, propidium iodide, a nuclear marker, was 
substituted for the primary antibody.   The secondary antibody/conjugate was omitted.   
Otherwise the protocol was followed as described above. 
 
2.2.4 EM PREPARATION  
All washes, post-fixation and dehydration were carried out in Petri dishes sitting on 
crushed ice to keep the vibratome sections flat.    After photo-oxidation the vibratome 
sections were washed for 5 x 3 minutes in 0.1M sodium cacodylate buffer and then post-
fixed with 1% osmium tetroxide made up in the same buffer, for 30 minutes.   The 
sections were transferred to individual glass Petri dishes washed a further 2 x 3 minutes in 
buffer and dehydrated in increasing concentrations of ethanol, starting at 50% continuing 
to 70%, 80%, 90% finishing at absolute.   Each step lasted 15 minutes and absolute 
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ethanol consisted of 2 changes of 15 minutes each.   Finally, the sections were infiltrated 
with Durcupan resin B which does not contain a hardening accelerator (see appendix 
5.2.4), diluted 1:1 with ethanol for 30 minutes and left overnight in Durcupan B diluted 
3:1 with ethanol.   The following day, the sections were left in Durcupan resin A, which 
contains hardening accelerator(see appendix 5.2.4) for 1hr in a 50˚C oven, then embedded 
in Durcupan A by placing each section on a glass slide coated with a compound release 
agent (Formen-Trennmittel, Hobbytime). A small amount of resin was carefully pipetted 
on to the section  and a second coated glass slide placed on top.   The two slides were 
clamped together with stationary bullfrog clips.   The slides were left in a 50˚C oven for 
the resin to polymerise a minimum of 24 hours. 
A razorblade was used to detach the resin sheet from the glass slides, the sections trimmed 
and then glued on to blank resin blocks with a drop of resin.    
Sections were cut for EM and grids stained as described in 2.1.8 
 
2.3 PAP and ABC 
Vibratome sections (see section 2.2.1.2) were used for both PAP and ABC staining.   All 
staining was carried out at room temperature unless otherwise stated. 
 For the PAP method, a secondary antibody (rabbit PAP complex) diluted 1:40 and a goat 
anti rabbit link antiserum, diluted 1:10, was used 
For the ABC method, a biotinylated secondary antibody was used together with a 
Vectastain ABC avidin biotin complex kit™ to enhance the signal.    
2.3.1 PAP STAINING  
 Endogenous peroxidase activity was blocked with freshly made 0.3% hydrogen 
peroxide/dH2O for 30 minutes. 
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After washing with running water, sections were treated with 10% normal goat serum 
(NGS) in PBS for about 2 hours at room temperature.   Excess NGS was removed and the 
primary antibody, diluted in 1% NGS/PBS, was immediately applied and sections were 
incubated overnight at 4°C.   The following day, sections were allowed to warm to room 
temperature and washed in PBS, 6 changes, for 30 minutes.   The appropriate link 
antibody diluted in 1% NGS was applied for 1 hour at room temperature and washed in 
PBS, 6 changes for 30 minutes.   Sections were incubated with PAP complex, 30 minutes 
at room temperature and washed in PBS, 6 changes, for 30 minutes.   The chromogen 
reaction was developed in filtered PBS containing 0.5 mg/ml DAB and 0.003% hydrogen 
peroxide/dH2O until the required colour change was seen (30 seconds to 5 minutes).   
DAB was removed by washing in PBS for 2 minutes and running water for 5 minutes.   
Sections were immersed in 1% osmium tetroxide/cacodylate buffer for 2 minutes before 
washing. 
Sections were dehydrated through alcohols, cleared and mounted in DPX.   For EM, 
sections were processed after osmication as for routine EM i.e dehydrated through graded 
ethanol, propylene oxide and embedded in Araldite similarly to the photo-oxidation 
method. 
2.3.2 ABC STAINING FOR EM 
100µm thick vibratome sections were transferred from a Petri dish to a 24 welled tissue 
culture dish (NUNC), separated to single slices per compartment.   The slices were 
submerged in solutions except for primary and secondary antibody solutions where the 
slices were merely kept covered in as little solution as possible, without drying out.   
Adding and withdrawing solutions were performed with a Gilson Pipette™.   Primary 
antibodies consisted of PLP226, AA3 and GFAP as a positive control.   Negative controls 
consisted of primaries being omitted and instead kept in blocking buffer, the rest of the 
schedule was performed as follows: 
The slices were washed in three changes of 20 minutes each with PBS, thereafter 
endogenous peroxidase activity was blocked with a solution of 0.3% hydrogen peroxide in 
dH2O for 30 minutes A blocking buffer consisting of 10% NGS, 0.2 % Triton X-100 in 
PBS to reduce non specific background staining and permeabilise cell membranes was 
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applied for 1 hour.   Slices were then incubated for 1 to 5 days with primary antibody 
solution made up in the same buffer as used for blocking except for NGS concentration 
being reduced to 1%.   Incubation was carried out in a 4°C fridge and solutions topped up 
as necessary.   The slices were thoroughly washed three x 20 minutes in 0.2 % Triton X-
100/PBS.   Next, incubation in a biotinylated secondary antibody solution, made up in the 
same buffer as for the primary, for 2 hours to overnight followed.   Further three x 20 
minutes washes in the same buffer was applied before an Avidin Biotin Complex. 
 
2.4   IMMUNOGOLD 
2.4.1 TISSUE PREPARATION   
2.4.1.1 Animal source 
Altogether 26 mice, 20 wild type and 6 Plp1 null, were used (see section 2.1.1 for detail).   
Ages ranged from P8 to P69.   In addition, tissue from 5 animals previously used for the 
photo-oxidation study, suitably fixed, was initially used.   Fixation varied and is described 
for the particular studies, see table 1. 
2.4.1.2 Fixation 
Several methods for fixation were explored to establish best possible preservation of 
antigenicity and morphology.   Animals were perfused and left for 8-12 hrs in 4˚C,  
1.   1% glutaraldehyde and 1% paraformaldehyde in 0.1M phosphate buffer (PB) pH 7.4 
(Maxwell and Riddell, 1999). 
2.   15% picric acid, 1% glutaraldehyde and 1% paraformaldehyde in 0.1M PB pH 7.4 (Li 
et al, 2001). 
 
 
3.   4% paraformaldehyde and 0.1% glutaraldehyde in 0.1M PB pH 7.4 (Tait et al, 2000). 
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2.4.2 EM PREPARATION 
Tissues were dissected as in section 2.1.3 extracting transverse sections of corpus 
callosum, transverse ventral columns and longitudinal dorsal columns sections of cervical 
spinal cord and whole optic nerves.    
Processing fixed tissue, for fixation methods 1 and 2 (see section 2.4.1.2), were as follows: 
The tissues were rinsed 6 times in 0.1M PB for 30 minutes followed by secondary fixation 
in 1% OsO4 in 0.1M PB for 30 minutes to 1hour.   Dehydration was carried out in rising 
concentrations of ethanol starting with 50% and finishing with 2 x 100%, 15 minutes each.   
Infiltration of resin (Durcupan) was carried out with 100% ethanol/Durcupan B (without 
hardener), dilution 1:1 for 1.5 hours, then 100% ethanol/Durcupan B, dilution 1:3 
overnight, finishing with Durcupan A (with hardener) only for 2 hours prior to embedding 
and curing in a 60
oC oven for 24 hours. 
Processing fixed tissue for fixation method 3 (see section 2.4.1.2), was as follows: 
Tissue blocks were kept in perfusion fixative for a further 2 hours (after perfusion) and 
then washed several times in 0.1M PB pH 7.4 (see appendix 5.3.1) containing 3.5% 
sucrose for 20 minutes.   Next, tissues were stained with 0.25% tannic acid made up in the 
wash buffer at 4°C for 1 hour.   To quench aldehydes 50mM ammonium chloride (NH4Cl) 
in 0.1M PB pH 7.4 was used for 30 mins.    Several washes in 0.1M maleate buffer pH 6.2 
(see appendix 5.3.2) containing 4% sucrose for 20 minutes was followed by en bloc 
staining with 1% uranyl acetate in the same maleate/sucrose buffer for 1 hour also carried 
out at 4°C.   Dehydration and embedding followed as for methods 1 and 2. 
Semi-thin sections (0.5µm) were cut and stained with routine azureII/methylene blue 
protocol (see 2.1.8) for light microscopy to identify areas to be cut for grids.   Thin 
sections (70nm) were then cut with a diamond knife (see section 2.1.8), floated out on 
water and picked up either directly on formvar coated slot (see appendix 5.3.3) or 
uncoated 200 mesh nickel grids or picked up together with a droplet of water on a nickel 
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loop and placed on coated slot grids.   Excess water was blotted off with a piece of filter 
paper and care taken to orientate sections on the grid.    
2.4.3 IMMUNOCYTOCHEMISTRY 
2.4.3.1 Primary antibodies 
Titres for PLP226 were established using ~70nm thin sections cut for EM, embedded both 
in Araldite and Durcupan.   Dilutions were approximated from routine use at 1:600 and 
increased in concentration to 1:450 and 1:300.   Similarly, titres for PLPA were tested at 
routine concentration of 1:1000 and further tested at 1:500 and 1:2000.   Anti-GABA 
(donated by Prof. Maxwell) and anti-GFAP were used at 1:1000. 
2.4.3.2 Secondary antibodies 
For the IG method initially a 10µm gold particle conjugate donated by Prof D. Maxwell 
was used, followed by a 10µm and a 2µm gold particle conjugated to an anti-rabbit IgG 
from Biotech.   The 10µm conjugate was put into Eppendorf vials in aliquots of 20µl, 
frozen and stored at -20°C.   Dilutions were initially kept to the same titre as used by Prof 
D. Maxwell (Maxwell et al, 1997)   
2.4.4 IMMUNOGOLD LABELLING 
2.4.4.1 Pre-embedding immunogold 
For pre-embedding IG staining vibratome sections were created as before (see sections 
2.2.1.2), to include sagittal cerebellar and transverse cervical spinal cord sections at 50µm 
thickness.   Staining protocol was used as by Prof Maxwell’s spinal cord research group 
(Olave et al, 2002) 
Immediately after cutting, the 50µm thick sections were transferred to a Petri dish with 
50% ethanol for 30 minutes to permeabelise.   After several washes in PBS the sections 
were left for 3 days in primary antibody solution, PLP226/PBS, concentration 1:600.    
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2.4.4.2 Post-embedding immunogold 
Staining protocol for tissue processed as per methods 1 and 2 (see section 2.4.1.2) were as 
follows: 
Grids were floated on droplets, of various protocol solutions, placed on Nescofilm™ in a 
Petri dish lined with water soaked tissue paper to prevent the grids drying out.   All steps 
were carried out at room temperature except that primary antibodies were applied 
overnight at 4ºC. 
Controls included sections where primary antibody was omitted (-ve) or a different 
primary antibody (+ve) was applied.    
Initially, the sections were treated with a blocking solution (PBST, pH, see appendix 
5.3.4) containing 10% NGS, to reduce non-specific binding and 0.1% Triton X-100 to 
increase membrane permeability in PBS for 1 hour.   The sections were then incubated 
with primary antibodies diluted in PBST with a reduced concentration of NGS to 1%.   
After overnight incubation, grids were subsequently washed thoroughly; first, in PBST 
then in TBST (Tris buffered saline containing 0.1% Triton X-100, pH 8.2, see appendix 
5.3.5) altogether for 1 hour.   The grids were then incubated for 2 hours with goat anti-
rabbit secondary antibodies conjugated to 2 or 10nm particles of colloidal gold (BBI) 
diluted in TBST.   Thorough washing followed; first, with TBST 2 x 10 minutes then 
distilled water 2 x 10 minutes.   If 2nm gold particles were used, grids were place on 
droplets of freshly mixed silver enhancing solution (Vectastain) for 5 to 10 minutes.   
Grids were then either left unstained or stained briefly with uranyl acetate and/or 
Reynold’s lead citrate. 
Staining protocol for tissue processed as per method 3 (Tait et al, 2000) (see section 
2.4.1.2) were as follows: 
Sections were blocked for 40 minutes with 1% BSA, 0.5% fish skin gelatine, 0.05% Triton 
X-100 and 0.05% Tween 20 made up in 10nM Tris buffer, pH 7.4, containing 500nM 
NaCl and then incubated with primary antibodies diluted in the same buffer overnight.   
The sections then went through 4 washes in blocking buffer before a 1 hour incubation 
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with secondary antibody IG conjugate took place.   After several washes in distilled water 
the sections were fixed in 2.5% glutaraldehyde/dH2O, further washed in a stream of dH2O 
before a secondary fixative consisting of 2% OsO4/ dH2O was applied.   The sections were 
finally stained with uranyl acetate and Reynold’s lead citrate. 
 
2.5 FREEZE SUBSTITUTION 
2.5.1 ANIMAL SOURCE  
Four wild type and 2 Plp null mice, aged P20-21were used.    
2.5.2 PROTOCOL 
Animals were humanely euthanased as described before (see 2.1.2).   Brain and spinal 
cord were immediately dissected out.   The tissue was kept submerged in PBS during 
dissection and transferred to be frozen as quickly as possible.   Areas of interest were 
chosen as before, see 2.4.2, to consist of transverse slices of corpus callosum, longitudinal 
and transverse slices of spinal cord.   Tissues were “rapid frozen” in liquid propane at -
187C
 o using a Reichert KF 80 cryo chamber;   propane was liquefied and kept at a 
constant temperature with liquid nitrogen; tissues were mounted on aluminium pins, 
attached to a plunger and propelled semi-automatically into the cryogen.   After freezing, 
the pins were transferred to NUNC tubes kept in liquid nitrogen.   The tubes were filled 
with pre-chilled 100% acetone, to dehydrate the tissue, and kept in a –90
oC freezer for 7 
days.   The tubes were refilled daily with fresh pre-chilled acetone.  The tissues were 
slowly brought to room temperature by transferring the tubes first to a –20ºC freezer for 2 
hours and then to a 4ºC fridge for 2 hours.   Osmication followed with freshly made 1% 
OsO4 in 100% acetone for 1 hour, dehydration for 2 x 15 minutes in acetone.   Infiltration 
and embedding with Durcupan resin followed as described in section 2.2.4 with acetone 
replacing ethanol. 
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CHAPTER 3    RESULTS 
 
3.1 CRITERIA FOR SUCCESSFUL LABELLING 
The aim of this thesis was to evaluate techniques for subcellular immuno-histochemical 
labelling which could be applied to the study of PLP biology.   PLP is localised 
predominantly in the compact myelin sheath. Therefore myelinated tract from the spinal 
cord and from the cerebellum of mice were used to critically evaluate a number of 
methodological aspects.   Outcome was assessed by visual observation to determine if the 
sections satisfied following criteria  
(I) The structure of tissue should be preserved. 
(II) There should be a differential labelling of myelin to non-myelin tissue. 
As part of an independent audit, approximately 50% of the sections were assessed by Dr 
C. Thompson and there was 100% concordance between her assessment and my 
assessment whether the sections satisfied these criteria. 
 
3.2 PHOTO-OXIDATION 
Photo-oxidation of eosin was used because the technique is verifiable at each stage and all 
equipment necessary was available.   The labelling can be confirmed at light microscopic 
level before proceeding to the electron microscopic level which eliminates unnecessary 
and time consuming processing of unlabelled tissues.     
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3.2.1 FIXATION 
Three fixatives, of varying glutaraldehyde concentrations were examined to establish a 
protocol for the photo-oxidation investigation which produced an adequate level of 
morphological preservation.   These results were contrasted with the excellent 
morphological preservation of myelin achieved by high concentrations of glutaraldehyde. 
Fixation with glutaraldehyde (0.1%) failed to produce acceptable myelin morphology.   
The intraperiod lines of the myelin were completely disrupted, myelin distorted as was the 
axons, see Fig. 3.1.   Furthermore the low concentration of glutaraldehyde left the tissue 
very soft resulting in wavy tissue thus making the nodes of Ranvier difficult to identify. 
Fixation with glutaraldehyde (0.5%) was also suboptimal for the myelin morphology 
displaying similar artefacts, although to a lesser degree. 
Fixation with glutaraldehyde (1%) produced acceptable morphological preservation for the 
myelin.   Intraperiod lines were still disrupted but key morphological features (myelin 
periodicity and axons) could be discerned and thus glutaraldehyde (1%) satisfied criteria I. 
3.2.2 CONJUGATION OF EOSIN 
Three conjugations were performed where the fluorophore eosin was attached to a goat 
antibody; firstly to a goat-anti-rabbit IgG which recognise PLP226 (two conjugations); 
secondly to a goat-anti-rat IgG which recognise AA3 (one conjugation). Both antibodies 
target myelin proteins PLP and DM20.    
Using spectrometry measurements the two goat-anti-rabbit conjugates consisted of 2 
molecules of eosin per IgG and 5.9 molecules of eosin per IgG, respectively.   The goat-
anti-rat conjugate consisted of 9.5 molecules of eosin per IgG. 
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FIGURE 3.1.   Electron micrographs of myelinated axons in the spinal cord ventral 
columns from adult mice showing the influence of glutaraldehyde concentration.  
A. Tissue fixed with 5% glutaraldehyde. 
B. Tissue fixed with 1% glutaraldehyde. 
C. Tissue fixed with 0.5% glutaraldehyde. 
D. Tissue fixed with 0.1% glutaraldehyde. 
Note the correlation in deterioration of myelin compactness and axon (Ax) shape to 
decreasing  glutaraldehyde concentration.  
Scale bar = 2µm 
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No significant difference was apparent on visual inspection in oligodendrocyte cultures 
stained with dialysed and undialysed solutions of eosin conjugated goat antibodies. 
SDS-PAGE gel eletrophoresis confirmed that the conjugations were successful but EITC 
fluorescent output was at a much lower level than FITC.   The EITC was of the order of 
20% of the FITC in accord with published data (Deerinck et al, 1994) (Fig. 3.2). 
3.2.3 TITRE 
Titres for the EITC to be used in the photo-oxidation method were established for each 
conjugate on dissociated oligodendrocyte cultures which were chosen because they were 
readily available, easily stained and avoided the need for sacrificing additional animals.   
Dilutions of 1:10, 1:50, 1:100 and 1:250 were examined because the FITC is used at a 
dilution of 1:80. 
EITC at a dilution of 1:10 had poor signal to noise because of the high background.   EITC 
at a dilution of 1:250 had a faint signal, although fine oligodendrocyte processes could still 
be seen.   EITC at dilutions of 1:50 and 1:100 both showed clearly labelled 
oligodendrocyte processes.    
Further tests between 1:50 and 1:100 were made.   The first eosin conjugate, goat anti-
rabbit was optimal at a dilution of 1:75, the second at a dilution of 1:85.   The third, an 
eosin goat anti-rat conjugate was optimal at a dilution of 1:50 (Fig. 3.3). 
These antibody titres were tested on cryostat sections to determine if the concentrations 
were appropriate for photo-oxidation and that PLP could be distinguished in sections.   
PLP was readily visible in the white matter of cerebellar folia (Fig. 3.4) using all three 
conjugates. 
3.2.4 PHOTO-OXIDATION 
Propidium iodide, a nuclear marker, was used instead of a primary antibody to test the 
photo-oxidation protocol.   Photo-oxidation of propidium iodide produced excellent results 
at LM level but equivocal results at the EM level.    
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                         Lanes                                     1       2      3      4       5 
 
 
 
 
FIGURE 3.2   SDS-PAGE acrylamide gel to confirm successful conjugation of 
EITC to rabbit IgG and comparison to FITC, visualised using a UV light 
 
Lane 1. Denatured EITC conjugate separated into fragments. Light chain (25 kDa ) and 
heavy chain (50 kDa). Bands are prominent in the undiluted sample.  
Lane 2. Diluted EITC conjugate 1:10. The heavy chain band can be discerned together 
with a faint band for the light chain. Both bands are approximately 20% of the 
equivalent band in lane 3. 
Lane 3. Diluted FITC conjugate 1:10. A clear band for the heavy chain and a lighter 
band for the light chain are clearly visible. 
Lane 4. Diluted EITC conjugate 1:50 Faint bands for the heavy chain can be discerned. 
Lane 5. Diluted FITC conjugate 1:50 Faint bands for the heavy chain can be discerned 
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FIGURE 3.3    Cultured oligodendrocytes immunostained with a PLP/DM20 primary 
antibody to determine secondary antibody concentration for optimal fluorescence. 
Upper.  Goat anti-Rabbit conjugated EITC 1:75 
Middle.  Negative control without primary antibody, goat anti-Rabbit EITC 1:75   
Lower.  Goat anti-Rabbit FITC 1:80.    
Scale bar A = 10µm, B, C = 20µm 
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FIGURE 3.4    Fluorescent images of myelinated axons in cerebellar folia to confirm 
appropriateness of titres.  
Indirect immunolabelling performed on 12 µm cryostat sections with a PLP/DM20 
antibody.   
A.  Myelin immunolabelled with a goat anti-rabbit IgG conjugated EITC secondary 
antibody.   
B.  Myelin similarly immunolabelled but with a FITC conjugated secondary antibody.   
Compare the intense staining of the axons with the less intense staining with EITC 
shown in image A above.    
C.  Negative control in the form of omission of the primary antibody PLP/DM20 . 
Scale bars = 20µm 
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During photo-oxidation, the EITC conjugate is irradiated in the presence of DAB, which is 
subsequently converted to a brownish reaction product by the excitation of the EITC 
molecule.   Propidium iodide reacts directly with DAB, forming a similar reaction product.   
Cerebellar sections, focused on the folium with both grey and white matter was used.   The 
photo-oxidation process were stopped by halting the irradiation which could easily be 
defined with continuous observation.  A medium brown spot, matching the restricted area 
formed by objective aperture size, with darker brown nuclei both in the grey and white 
matter, was clearly seen under the light microscope (Fig. 3.5a & b).   However, at EM 
level no discernable staining could be detected.   This observation must be treated with 
caution.   If a light homogenous “sprinkling” of very fine grains it could easily be missed 
due to contrast staining of the tissue. 
The photo-oxidation protocol was applied to both cerebellar and cervical spinal cord 
vibratome sections.   An antibody (PLP226) against PLP and DM20, targeting the C-
terminal of the proteins, was used.   This antibody was very reliable on LM and FM 
preparations.    
After photo-oxidation the tissue appeared well labelled at LM level.   Dark brown 
“strands” corresponding to myelinated processes could be seen in the white matter of 
sagittal cerebellar sections (Fig.3.6) and similarly in longitudinally sectioned spinal cord 
sections.   In transverse section, the myelin around axons was easily observed as brown 
rings surrounding pale axonal centres.    Because photo-oxidation took place in a 
fluorescence microscope, I was able to check that the tissue was labelled by switching 
between a FITC cube for fluorescence viewing and a triple cube for photo-oxidation 
viewing (Fig.3.6).   The optical density of the reaction product was established through 
timed exposure ranging from 5 min. to 30 min.   At 5 minutes exposure, no specific 
labelling was observed although the brown background labelled circle had appeared and at 
30 minutes overexposure had obscured the specific labelling against the darker 
background.   Although the LM result appeared positive and labelled as expected, there 
was no evidence of labelling at EM level in contrast stained sections.   On 30 occasions 
(each with 4 sections) successful labelling was observed at LM level with no reaction 
product seen at EM level in contrast stained sections (see Table 1). 
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FIGURE 3.5a    Light microscopy images of cerebellar folium, showing photo-
oxidised area restricted by objective aperture size.    
A.  Nuclei, in molecular and granular layer, labeled with propidium iodide after 
photoconversion   
B.  Schematic representation of photo-oxidised sections in A and B.   Two layers in the 
cerebellar folia are visible, the molecular layer (ML), granular layer (GL). Black dots 
represent stained nuclei seen in section A only;   
C.  Control showing photo-oxidised area of section with no propidium iodide 
incubation. Note lack of stained nuclei.                                                     Scale bars A, C 
= 100µm. 
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FIGURE 3.5b    Light microscopy images as in figure 3.5a (at higher magnification) 
highlighting labelled cell nuclei.  
A.  Cerebellar folia showing photo-oxidised area restricted by objective aperture size.   
Inset area representing figure B;   
B.  High magnification of photo-oxidised cerebellar molecular layer showing labelled 
cell nuclei. 
Scale bars A = 100µm. B = 20 µm 
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FIGURE 3.6    Successful photo-oxidation of myelin at LM resolution. 
A.  Fluorescence image of myelin (prior to photo-oxidation) in white matter between 
cerebellar folia labelled with rabbit anti-PLP antibody followed by a goat anti-rabbit 
eosin conjugate   
B.  The same section after photoconvertion. 
Scale bars A, B = 100µm. 
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TABLE 1:  Optimisation of Photo-oxidation : Factors varied   
                   
Exp no  Animal   Genotype  Tissue  Age  Fixation  Type experiment  Ab1  Ab2   
PO 1  mouse  WT  sag cereb 50µm     4% para add 0.1glut  po  PI      
PO 7  mouse   WT  sag cereb,cerv 50µm  P6weeks  4% para 0.1% glut  po  PLP226  EITC#1   
PO7A              " " "  "  "  po PLP226 EITC#1
PO7B                    " " " " " po PLP226 EITC#1
PO7C                    " " " " " po PLP226 EITC#1
PO7D                    " " " " " po PLP226 EITC#1
PO 8  mouse   WT  sag cereb,cerv 50µm  P6mo  4% para 0.5% glut  po  PLP226  EITC#1   
PO 9  mouse  WT  sag cereb,cerv 50µm  P6mo  4% para 1% glut  po  PLP226  EITC#1   
PO 9C  "  "  sag cereb 70µm  "  "  po  PLP226  FITC   
PO 9D  "  "  sag cereb,cerv 50µm  "  "  po w NaBH4  PLP226  EITC#1   
PO 16   mouse  WT  sag cereb,cerv 50µm  P22  4% para 1% glut  po  PLP226/GFAP  EITC#2   
PO 16A  "  "  sag cereb vibs 50µm  "  "  po  PLP226/GFAP  EITC#2   
PO 16B  "  "  sag cereb vibs 50µm  "  "  po  PLP226/GFAP  EITC#2   
PO 16C  "  "  "  "  "  po  PLP226/GFAP  EITC#2   
PO 17  mouse  WT  sag cereb,cerv 70µm  P22  4% para 1% glut  po  PLP226/GFAP  EITC#2   
PO 18  mouse  WT  "  P19  4% para 1% glut  NA         
PO 19  mouse  WT  "  P19  4% para 1% glut  po  PLP226/GFAP  EITC#2   
PO 19A  "  "  sag cereb vibs 50µm  "  4% para 1% glut  po  PLP226/GFAP  EITC#2   
PO 19B  "  "  sag cereb vibs 50µm  "  4% para 1% glut  po  GFAP  EITC#2   
PO 19E  "  "  sag cereb vibs 70µm  "  4% para 1% glut  po  PI      
PO 20  mouse  WT  sag cereb vibs 50µm  P16  4% para 1% glut  po  GFAP  EITC#2   
PO 20B  "  "  cereb vibs 50µm  "  4% para 1% glut  po  GFAP  EITC#2   
PO 20E  "  "  cereb vibs 50µm 70µm  "  4% para 1% glut  po  GFAP  EITC#2   
PO 21  mouse  WT  "  P17  SF  po  PLP226/GFAP  EITC#2   
PO 22  mouse  WT  "  P17  SF  po  PLP226/GFAP  EITC#2   
PO 22A  "  "  "  "  "  po  PLP226/GFAP  EITC#2   
PO 26  "  "  "  "  4% para 1% glut  po  AA3                  EITC#3      
PO 26B  "  "  "  "  4% para 1% glut  po  AA3                  EITC#3      
PO 27  mouse  WT  Astro TC   7 div  4% para 0.1% glut  po  GFAP  EITC#2   
PO 29  mouse  WT   Astro TC   7div  4% para 0.1% glut  po  GFAP  EITC#2   
PO 31  PO 22  WT  sag cereb vibs 50µm  P17  SF  po  PI      
                   
No compelling demonstrations of photo-oxidation product associated with myelin were obtained in these experiments (see text for details) 
         
 
         
Age:  Postnatal ages for mice days, weeks, months    For astrocytic cultures days in vitro (div)       
Tissue:  Vibratome sections of sagital cerebellum (sag cereb), cervical spinal cord ventral columns (cerv), astrocyte tissue cultures (Atsto TC). 
  Section thickness is indicated.             
Ab1:  Type of primary antibody used             
  P1:  propidium iodide for nuclear labelling             
  PLP226 for PLP/DM20, GFAP for astrocytes             
Ab2:  Type of secondary antibody used :             
  EITC #1 and #2 represent two different conjugations of eosin 5-isothiocyanate, FITC represents fluoroscein 5-isothiocyanate 
Type experiment:  photo-oxidation (PO), photo-oxidation with tissue quenched for autofluorescence (PO w. NaBH4)       
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To determine if the lack of staining at EM level was due to weak immuno-labelling of PLP and 
DM20, an antibody against GFAP was used as this provides a strong labelling of intermediate 
filaments in astrocytes.   Sagittal cerebellar sections were used because astrocytes in the shape of 
Bergmann glia run densely through the molecular layer of the folium.   The photo-oxidation protocol 
was applied as before and Bergmann glia was observed at LM level but not at EM level in contrast 
stained sections. 
3.2.5 IMMUNOHISTOCHEMISTRY 
Failure to detect photo-oxidation labelling of EITC at EM level may be a consequence of inadequate 
signal, either because the 70nm EM sections cannot hold enough of the reaction product or that the 
low fluorescing ability of eosin is not enough to be detected at EM level. Therefore I employed the 
ABC method. Using ABC , anti-GFAP gave excellent labelling at dilution of 1:1000 at LM level.   
Bergmann glia in the cerebellar molecular layer was strongly labelled (Fig.3.7).   PLP226 had to be 
tested at various dilutions, 1:300, 1:600 and 1:1200.   The ABC labelling of PLP226 at the dilution of 
1:1200 clearly showed visible strands, identifiable as longitudinally orientated myelinated axons.   
Higher concentrations of PLP226 gave a high background.   A different antibody (AA3) against PLP 
and DM20 was tested to preserve our group’s finite pool of PLP226.   This antibody gave an identical 
labelling to PLP226 although slightly finer and weaker (Fig. 3.7).   The EM picture for both antibodies 
was found to be unsatisfactory for our main purpose of differential localistation for PLP and DM20.   
To critically assess if the photo-oxidation technique would give an adequate EM picture of the 
oxidised DAB product, I used GFAP since it gives a stronger signal than PLP226 and AA3 at LM 
level.   The filaments are found throughout the cytoplasm of astrocytes and its processes, which 
should be easily identifiable.   At EM level, the fine reaction product at lower concentration levels was 
difficult to recognise and at higher concentration tended to destroy the morphology of the tissue.   The 
DAB product was diffuse and covered large areas around the filaments.   Whole processes of 
Bergmann glia were heavily stained (Fig. 3.8) resulting in excessive hardening of the tissue during 
processing, therefore rendering the tissue fragile and easily prone to ripping.   Additionally the 
reaction product was not readily found in every section. 
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FIGURE 3.7   Astrocytes and myelinated axons in cerebellar folium, labelled with anti-
GFAP or anti-PLP antibodies and stained with an avidin-biotin complex (ABC) at LM 
resolution. 
A.  Bergmann glia in the molecular layer and protoplasmic astrocytes in the granular layer;   
 B.    Negative control section showing unlabelled molecular and granular layer;   
 C.    High magnification of Bergmann glia;   
 D.    Myelinated axons in cerebellar folium white matter. 
Scale bars = 20 µm 
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FIGURE 3.8    Astrocytes in cerebellar folium, labelled with anti-GFAP and stained with an 
avidin-biotin complex (ABC) at EM resolution. 
Three illustrative examples of labelled astrocytes (Bergmann glia) processes (arrows) in the 
cerebellar molecular layer at different levels of magnification showing morphological disruption of 
the tissue. The reaction product was difficult to recognise at low concentrations whereas in these 
examples of higher concentrations tended to destroy the morphology of the tissue. The EM results 
contrasted with excellent labelling at LM resolution (see figure 3.7).            
          Scale bars 5µm. 
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Failure to detect photo-oxidation labelling of EITC at EM level may be due to obscuring the reaction 
product by contrast staining with uranyl acetate and lead citrate which is needed to view sections in 
the electron microscope (see section 2.1.7).   To determine if this was the case I examined unstained 
sections after photo-oxidation and EM processing.   Sections without contrast staining appear white 
and translucent in the EM and such sections are difficult to focus on or to see fine details.   The JEM 
CX-100 II transmission electron microscope has 4 different objective lens appertures numbered 1-4 in 
decreasing order of size, creating higher contrast with decreasing size.   Routine viewing takes place 
with a number 2 objective lens and with this size no labelling was immediately apparent.   With the 
smallest size objective apperture i.e. number 4, I was able to detect very fine lines of dotted reaction 
product using anti-PLP antibody 226 (Fig.3.9).   Only after negatives were scanned into a computer 
and the pictures further contrast enhanced with Adobe Photoshop software was a confirmation of 
labelling was possible.   Controls were examined in the form of anti-GFAP and anti-PLP antibody 
AA3 and labelling using the photo-oxidation method confirmed (Fig. 3.10). 
The photo-oxidation technique was found to be unsuitable for subcellular differential localisation of 
PLP/DM20 because of the difficulty in producing a viable EM image of the DAB reaction product.  
Although the product might be seen and recorded after some manipulations, the possibility of finding 
specific regions i.e. nodes of Ranvier in unstained sections would be a formidable task.   The 
challenge of labelling myelin trans-membrane proteins requires a technique that produces a reaction 
product that is larger and has a more specific reaction product than the diffuse DAB reaction product.   
Together these findings led me to discontinue further research with the photo-oxidation method. 
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FIGURE 3.9 Electron micrograph of myelinated axons (Ax) in cerebellar white matter from an adult 
mouse after photo-oxidation of EITC in the presence of DAB. The EITC was conjugated to a 
secondary antibody recognising a primary antibody against PLP/DM20. The sections appeared 
immunolabelled, although the labelling was only detectable when sections without contrast staining for 
EM and high contrast objective aperture were used. Note the alignment of the reaction product 
seemingly following myelin membranes. Whether the reaction product was situated on the intraperiod 
line was not possible to ascertain due to lack of resolution at high magnification. There appear to be an 
unlabelled membrane (see arrow in inset) possibly the major dense line.       Scale bar = 1 µm. 
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FIGURE 3.10  Electron micrograph of myelinated axons (Ax) in cerebellar white matter from an 
adult mouse after photo-oxidation of EITC in the presence of DAB. 
A.The section was labelled with an anti-GFAP antibody. Note the heavy deposit of reaction product 
that although covering underlying structure is in concordance with the anatomical localisation of 
astrocyte processes. Also note the apparent lack of labelling of the myelin around the axons (Ax) 
(see inset) in contrast to the reaction product in Figure 3.9. 
B. The section was labelled with a different anti-PLP/DM20 antibody from the antibody used in 
Figure 3.9. The myelin appear similarly labelled although with a much finer reaction product in 
concordance with findings at light microscopic level. The inset shows an inverted higher 
magnification, note the fine lines of product different from the labelling in A.                                                        
Scale bars A, B = 1 µm    
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3.3 EVALUATION OF IMMUNO GOLD TECHNIQUES 
The immunogold technique was used to evaluate if PLP/DM20 can be labelled at EM level because 
unlike the photo-oxidation technique the immunogold method produces a specific and distinct reaction 
product (Fig. 3.11). 
3.3.1 PRE- AND POST-EMBEDDING TECHNIQUES 
One pre-embedded and one post-embedded immunogold schedule were performed.   For pre-
embedded, silver-intensified staining, two wild type mice were perfused with glutaraldehyde (1%) / 
paraformaldehyde (1%) in phosphate buffer (0.1M).   The spinal cord was dissected and left in 
fixative over night.   Vibratome sections were stained as described in detail in section 2.4.4.   Formvar 
coated nickel (Ni) slot grids were obtained and stained. 
For the post-embedded method glutaraldehyde (1%) fixed tissue, previously embedded for the photo-
oxidation method was used.   Formvar coated Ni slot grids were obtained and stained. 
In white matter of the spinal cord (with the intrinsic problems connected with the high lipid content) 
the pre-embedded method yielded no result i.e. few gold particles could be found in the tissue.   Due 
to either long incubation time or the permeabilising technique the morphology of the tissue was 
unacceptable for my purpose.   Therefore, the pre-embedding method was excluded at this stage. 
The post-embedded method appeared to have the potential to produce successful labelling of white 
matter of the spinal cord.   However, the specificity of the observed labelling was difficult to evaluate.   
Most grids had wrinkled tissue or support film (formvar), which promotes staining contamination, and 
so obscured results.   The spread of gold particles were patchy with high background labelling.   
Nonetheless, the presence of some labelling provided a basis for optmisation of the immunogold 
method for spinal cord investigation. 
  63   
 
 
 
FIGURE 3.11 Comparison of two different immunocytochemical reaction products. 
A. Modified electronmicrograph (from Huang et al, 1997) of the reaction product from photo-
oxidation of an antibody labelling the perinucleolar compartment in HeLa cells. The photo-
oxidation took place in the presence of DAB which was converted to an electrondense reaction 
product. Note the diffuse nature of the labelling arranged both inside the nucleolus (Nu) and the 
nucleoplasm.  
B. Modified electronmicrograph (from Maxwell et al, 1997) of immunogold reaction product (10-
15nm gold particles) used to label glutamate in the bouton of a dorsal horn interneuron. Note the 
large, smooth electrondense goldparticles of this product compared to the product of DAB in A. 
Scale bars A = 1 µm, B = 50.5 µm. 
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3.3.2 IMPROVING QUALITY AND SPECIFICITY OF IMMUNOGOLD 
LABELLING 
A systematic analysis of constituent elements of the immunogold labelling techniques was undertaken 
to evaluate the post-embedding method as applied to tissue with high lipid content such as spinal cord 
white matter.   Types of grids were changed to assess if support film was necessary thus avoiding 
wrinkles.   All solutions were filtered to eliminate contamination that can be mistaken for label.   
Controls were introduced to corroborate specificity of labelling.   Three different fixatives were used 
to evaluate if the strength of signal could be improved.   Freeze substitution was employed, which 
circumvents the initial use of a chemical fixative thus rendering hydrophobic epitopes immobile 
during processing and more accessible to immunostaining.   Lastly the age of animals were varied to 
determine whether immature and less compact myelin allows greater access to the PLP/DM20 antigen 
than mature, fully compacted myelin. 
MESH GRIDS 
Many EM techniques advocate the use of a support film (formvar, see appendix 5.3.3) for the tissue 
sections in order to use grids with a larger mesh (see section 2.1.7).   This has the advantage of 
allowing observation of the tissue section either in its entirety or in large segments without grid bars 
obscuring the view.   The disadvantages are that thickness is increased which reduces microscope 
resolution and wrinkles can be formed both in the film and the tissue.   To avoid wrinkles on formvar 
coated slot grids (see appendix), eliminate contamination and improve labelling, uncoated Ni mesh 
grids were used (Fig.3.12).   The immunolabelling was stronger, possibly due to antibodies reaching 
the tissue on both sides of the section.   However the sections were very unstable in the electron beam 
due to the low level of fixation and long staining protocol (compared to routine contrast staining for 
EM sections).   Also, longitudinal sections of nervous tissue become physically weak due to the 
anatomical features of nerves with shearing between the neuropil and the compact, fatty myelin.   Too 
many sections were lost to make this a viable option other than confirm labelling on transverse 
sections. 
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FIGURE 3.12    Influence of grid type on immunogold labelling.  
Electron micrographs of myelinated axons in spinal cord ventral columns. The sections were 
labeled with a PLP antibody and immunogold stained with a secondary rabbit IgG conjugated to 
10nm gold particles.    
A.  Section is carried on an uncoated 300 mesh Ni grid. Note increased label and high background;   
B.  Section is carried on a formvar coated Ni slot grid.   Note the lower level of immunogold 
labeling but with low background compared to that in uncoated grid. 
Scale bars. A, B = 0.5µm  
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FILTERING 
Due to the long staining schedule, sections were very prone to pick up foreign material (e.g. dust, 
impurities in reagents, unconjugated components of IgG sera) in solutions that were amplified by 
contrast staining with uranyl acetate and lead citrate.   Elimination of a large proportion of 
contamination was achieved by micro filtering all solutions.   The rest of the contamination could 
usually be eliminated as artefacts during observation in the EM because gold particles were perfectly 
round, dense and smooth whereas the contamination had an irregular or less dense appearance. 
POSITIVE AND NEGATIVE CONTROLS 
A series of positive and negative controls were employed to assess the immunogold method or 
specificity of PLP labelling.   An antibody against GABA, a neurotransmitter, kindly donated by Prof 
Maxwell, compatible with the rabbit IgG-coupled gold as a positive control displayed a widespread 
and intense labelling pattern in the ventral columns of the spinal cord.   The utility of GABA 
immunogold labelling was rejected as a suitable positive control because of its anatomical location 
(grey rather than white matter) and intensity.   A second positive control, the same anti-GFAP as for 
the photo-oxidation method, was used.   The GFAP antibody was confirmed as positively labelling 
astrocyte cytoplasm (Fig.3.13).   The GFAP antibody also provided a negative control since the lack 
of label in myelin was confirmed.   Additional negative controls were added in the form of omission 
of primary antibody with no other modification of the experimental protocol.   These negative controls 
were almost always devoid of gold particles, as expected, thus confirming that loose particles would 
not adhere by themselves.   Further and more important negative controls were added using tissue 
from the Plp1 null mice (Fig.3.13). 
FIXATION 
Fixation with glutaraldehyde (1%) yielded tentative immunogold labelling of spinal cord myelin and I 
had already demonstrated this fixation was preferred option for photo-oxidation.   Two additional 
fixatives which had been employed with success in immunogold labelling of CNS tissue, one fixative 
in grey matter (Li et al, 2001) and one fixative in paranodal loops of white matter myelin (Tait et al, 
2000) were investigated.    
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FIGURE 3.13    Electron micrographs of spinal cord sections, stained with immunogold, and used 
as positive and negative controls for the antibody PLP 226. 
Axons are indicated by asterisks, neuronal nucleus is indicated by Nu. 
A. Positive control. Shows an antibody (GFAP) labelling intermediate filaments found in 
astrocytes.   Note gold particles following an astrocyte process and lack of labelling in myelin (see 
arrows); 
B.  Positive control.   Shows and antibody (GABA) labelling neurotransmitter substance found in 
neurons. Note general spread of gold particles and lack of high specificity; 
C. Negative control.Shows a section of transgenic PLP null tissue stained with the antibody PLP 
226.Note the lack of gold particles in myelin (see arrows).Scale bars=1u 
  68   
Three different fixatives were compared; fixative a) glutaraldehyde (1%) and paraformaldehyde (1%) 
in phosphate buffer (0.1M).   This provided a baseline for optimisation.   Fixative (b) comprising 
picric acid (15%), glutaraldehyde (1%) and paraformaldehyde (1%) in phosphate buffer (0.1M), to 
investigate addition of picric acid and fixative (c) comprising paraformaldehyde (4%) and 
glutaraldehyde (0.1%) in phosphate buffer (0.1M) to compare a lower concentration of 
glutaraldehyde. 
The results showed that there were no systematic differences in labelling between fixative (b) and 
fixative (c).   There was no systematic improvement in overall utility with either fixative (b) or 
fixative (c) compared to the reference fixative (a).   With fixative (b) and (c), the tissue had a much 
cleaner background and better labelling than with fixative (a) however the morphological preservation 
of tissue was inferior than with fixative (a) see Fig 3.14.     
FREEZE SUBSTITUTION 
Freeze-substitution was used to avoid primary chemical fixation leaving the hydrophobic PLP/DM20 
proteins static (frozen) whilst the tissue was dehydrated, secondarily fixed with osmium tetroxide and 
embedded. 
Previous immunogold staining, using chemical fixations (see section 3.3.2), frequently showed gold 
particles more concentrated in disrupted myelin (Fig.3.15).   This pattern could be caused either by a 
physical artefact or because access to membrane-bound epitopes are increased due to the separation of 
the myelin lamellae. 
The results using freeze-substitution as primary fixation method greatly increased specific labelling.   
However, axons and surrounding neuropil tended to be ice damaged to various degrees (Fig.3.16). 
EVALUATION OF GOLD PARTICLES SIZE 
Two different gold particle sizes were used to evaluate if access to the PLP/DM20 protein using the 
primary antibody PLP226, which targets the intracellular C-terminal, could be   improved. 
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FIGURE 3.14    Electron micrographs of myelinated axons (Ax) in spinal cord ventral columns displaying 
the impact of various fixatives.    
Sections were labelled with a PLP/DM20 antibody and immunostained with a secondary rabbit IgG 
conjugated to 10nm gold particles. The immunostaining were used to compare three different fixations, 
facilitating a comparison for choosing suitable fixation to labelling of myelin.   All fixatives were made up in 
0.1M phosphate buffer pH 7.4.    
A.  Tissue fixed with glutaraldehyde (1%) and paraformaldehyde (1%)  
B.  Tissue fixed with picric acid (15%) and paraformaldehyde (1%) 
C.  Tissue fixed with glutaraldehyde (0.1%) and paraformaldehyde (4%) 
Note the poor preservation of myelin in B and C, clearly inferior to A. 
Scalebar A = 0.5µm, B, C = 1µm. 
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FIGURE 3.15    Immunogold labelling associated with myelin disruption.    
Electron micrograph of myelinated axons (Ax) in the spinal cord ventral columns fixed in a 
glutaraldehyde (1%), paraformaldehyde (4%) solution.   The section was labelled with a PLP 
antibody and immunogold stained with a secondary rabbit IgG conjugated to 10nm gold particles.   
Note the prevalence for labelling in disrupted myelin (arrows). 
Scale bar = 0.5µm. 
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FIGURE 3.16    Freeze substitution increased specific immunogold labelling.    
EM micrographs of myelinated axons (Ax) in spinal cord ventral columns using freeze substitution 
fixation. The sections were labelled with a PLP antibody and immunogold stained with a secondary 
IgG conjugated to 10nm gold particles. The two illustrative examples shows well labeled myelin 
with ice damage in the neuropril. Note the lack of ice damage to the myelin and excellent resolution 
of myelin lamellae. 
Scale bar A = 1µm, B = 0.3µm. 
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Medium and small sized gold particles, 10µm and 2µm respectively were used (Fig.3.17). 
 The 2µm particle was used to increase the penetration of membranes but gave no discernible label.   
A silver intensification of the applied 2µm particle was used to increase the size resulted in a reaction 
product that became too large, obscuring true label.   The silver intensification method was however 
important in confirming that the myelin of Plp1 null mice was not being labelled and could therefore 
be used as negative control (Fig.3.18).   The medium sized gold particle was clearly seen in the EM 
and was used for the majority of immunostaining. 
3.3.3   IMMUNOLABELLING OF PLP 
With improved immunogold technique the pre-specified criteria i.e. that the structure of tissue should 
be preserved and that there should be a differential labelling of myelin to non-myelin tissue, were met 
to an adequate level for localisation of PLP/DM20, however, not to a standard necessary for a 
quantitative morphometric study. Assessment was made on 400 grids, 30 immunostainings with 10-15 
grids each time.   Negative controls in the form of omission of primary antibody, were always 
included and always negative.   Further negative controls were created by the use of PLP null animals.   
Positive controls were included as anti-GFAP and anti-GABA.   Anti-GFAP were included in 11 
immunostainings and were positive in 8.   Anti-GABA were included in 6 immunostainings but 
rejected as previously described.   Tissue from PLP null animals was included in 16 immunostainings 
and varied in labelling although the silver enhanced small gold particle preparation showed a 
convincing lack of PLP label thus confirming that wild type myelin was labelled (Fig.3.18).   
Assessments were confirmed independently by Dr C Thomson who was in 100 % concordance with 
my findings.   Assessments were made using anti-PLP226 both in mature animals (P17-P20) with PLP 
at its peak of production, the myelin compacted and well established and young animals (P8-P10) with 
PLP in its beginning of production and less compacted.   Ventral columns in cervical spinal cord 
which has a dense population of medium to large myelinated axons were used.   The labelling was 
surprisingly low in young animals with a rough estimate of 5-30 gold particles per medium size axon 
in the transverse plane (Fig.3.19).   The axon itself contained approximately between 1–10 gold 
particles.   In mature animals labelling was much higher although background was increased as well, 
therefore, specific labelling was probably much less than it appeared to be (Fig.3.19).    
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FIGURE 3.17    Influence of gold particle size on immunolabelling.    
EM micrographs of myelinated axon (Ax) in spinal cord ventral columns.   The sections were labelled with 
an anti-PLP antibody and immunogold stained with a secondary rabbit IgG conjugated to different sizes of 
gold particles.    
A.  10nm goldparticles. Note the well defined labelling with these larger gold particles in the myelin sheath;   
B.  2nm goldparticles. Note the absence of recognisable labelling;   
C.  2nm gold particles with silver enhancement Note the high level of specific labelling. 
Scalebar A = 0.3µm, B = 0.2µm, C = 1µm 
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FIGURE 3.18    Confirmation of immunogold labelling using knockout mice. 
Electron micrographs of, silver intensified immunogold labelled, central columns in cervical spinal 
cord sections. Comparison of distribution of immunoreactivity of PLP/DM20 between (A) wild 
type and (B) plp/null mouse. Although high background staining, clearly defined axons can be seen 
in the wild type tissue (A) see arrows.    
Scale bars A, B = 10µm. 
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FIGURE 3.19    Comparison of immunogold labelling of myelin in young and mature animals. 
Electron micrographs of immunogold stained, anti-PLP labelled myelinated axons (Ax) in spinal cord ventral 
columns.    
A. 20 day old mouse with mature myelin using freeze substituted tissue    
B. 8 day old mouse with immature myelin using tissue fixed with glutaraldehyde(1%)/ paraformaldehyde 
(1%). Note the higher level of staining in mature animals compared to younger animals.                                                        
Scale bar A, B = 0.5µm. 
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The labelling was often more concentrated in disrupted myelin, an artefact due to the compromise in 
choice of fixative.   In longitudinal sections the labelling was clearer, particularly if an axon was cut 
slightly obliquely with myelin lamellae sheared off at one end (Fig.3.20).   The gold particles were 
then denser at the disrupted layers of myelin perhaps through increased access to the antigen.   Gold 
particle distribution was often intermittent and sometimes closely grouped.   The low and intermittent 
phenomenon could perhaps be explained as a difficulty in labelling an amphipathic transmembrane 
protein with its limiting access to the epitope of interest or the limited amount of epitopes available in 
a 70nm section.   The clumping was almost certainly an artefact, either of the gold conjugate itself (it 
is not an uncommon problem with gold) or background labelling.   Very few paranodal loops were 
observed since the internodes are comparatively long in the ventral columns; hence, few nodes of 
Ranvier are present in a 70nm section.   The few loops that were observed were always either 
completely devoid of gold particles or had very few particles sprinkled in the cytoplasm (Fig.3.21). 
On 6 occasions, assessment was also made of anti-PLP A, targeting exon 3B which is missing in the 
DM20 molecule thus specifically reacting with PLP only.   Ventral columns in spinal cord sections 
were used, in mature animals only, together with the freeze substitution method.   The need for strong 
labelling eliminated the use of young animals and the chemical fixation protocols.   The results were 
similar to anti-PLP226 but with a weaker signal therefore making a comparison difficult. For an 
overview see tables 2& 3. 
The decision not to pursue the study further with a morphometric method, suitable for robust 
quantitative analysis, was taken because the labelling was too weak and the background too high.   
The staining was also very patchy and varied from staining to staining, although not in itself a 
problem, making this study too labour intensive, expensive and time-consuming. 
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FIGURE 3.20  Electron micrographs of myelinated axons in spinal cord ventral columns, oblique 
orientation, displaying level of immunogold labeling.   Sections were labelled with an anti-PLP 
antibody and immunogold stained with a secondary rabbit IgG conjugated to 10 nm gold particles.   
Note (arrows) increased gold particles in the myelin at oblique end of axons (ax) which confirms 
the inaccessibility of PLP. 
Scale bar A, B = 1µm  
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FIGURE 3.21. Electron micrograph of paranodal loops at  the node of Ranvier displaying level of 
immunogold labeling in young animals. 
The tissue was taken from spinal cord white matter, containing myelinated axons (Ax), of an 8 
day old mouse. The section was immunogold stained and labelled with an antibody recognising 
PLP/DM20. Note the low level of label in both the compact myelin (black arrow) and paranodal 
loops (white arrows). 
Scale bar = 1µm 
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TABLE 2             Evaluation of immunogold labelling : Fixation      
           
Animal 
Code Fixative  Age Type Label  Background  
            PLP226  PLP226   
Au 1  picric 15%/1% PF/1% glut/0.1MPB pH7.4  p28  WT  xxx  x   
Au2  picric 15%/1%PF/1% glut/0.1MPB pH7.4  p28  WT  xxx  x   
Au3  1%PF/1%glut/0,1M PB pH7.4  p28  WT  xxx  xx   
Au4  4%PF/5%glut/NaCac pH 7.2  p28  WT  xx  xx   
Au5  picric 15%/1% PF/1% glut/0.1M PB pH7.4  p69  KO  x  o   
Au6  picric 15%/1% PF/1% glut/0.1M PB pH7.4  p69  WT  xxx  xx   
Au7  1%PF/1%glut/0.1M PB pH7.4  p69  KO       
Au8  1%PF/1%glut/0.1M PB pH7.4  p69  WT  xxx  xxx   
Au9 4%PF/0.1%glut  p8  WT  xx o   
Au10  1% PF/1%glut/0.1M PB pH7.4  p8  WT  xx  x   
Au11  1% PF/1%glut/0.1M PB pH7.4  p11  KO  o  x   
Au12 4%PF/0.1%glut  p11  KO       
Au13  1% PF/1%glut/0.1M PB pH7.4  p8  WT  x  x   
Au14 4%PF/2.5%glut  p8  WT       
Au15  1%PF/1%glut/0.1M PB pH7.4  p8  WT  xx  o   
Au16  1% PF/1%glut/0.1M PB pH7.4  p8  WT  xx  x   
Au17  1% PF/1%glut/0.1M PB pH7.4  p8  WT  xx  x   
Au18  1% PF/1%glut/0.1M PB pH7.4  p8  WT  xx  xx   
Au19  1% PF/1%glut/0.1M PB pH7.4  p8  WT  x  o   
Au20  1% PF/1%glut/0.1M PB pH7.4  p8  WT  o  o   
Au21  1% PF/1%glut/0.1M PB pH7.4  p8  WT  xx  x   
           
Fixatives : Detailed information on the fixative is to be found in methods sections      
paraformaldehyde (PF), gluteraldehyde (glut), Phosphate buffered saline (PB),  sodium Cacodylate (NaCac) 
           
Age:  Post natal age (days)           
Type:  WT : wild type mouse, KO : plp null mouse           
Label:  The extent of gold particles associated with myelin with anti-PLP antibody (PLP 226)  
Background:  The extend of gold particles in the neuropil or in axons not associated with myelin 
           
*** Abundant          
** Moderate          
* Few           
o none           
-  not available for retrospective analysis           
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TABLE 3    
Evaluation of immunogold labelling : Freeze Substitution    
                  
Animals Processing  Age 
Geno-
type Label  Background Label  Background  
           
PLP 
226 PLP  226 
PLP 
A PLP  A     
IG-FS1 
Freeze 
substitution  p20  WT  xxx x xx x     
IG-FS2 
Freeze 
substitution p20  WT  xxx  x  x  x     
IG-FS3 
Freeze 
substitution p21  WT  o  o  o  o     
IG-FS4 
Freeze 
substitution  p21 WT  o  o  o  o     
A2414 
Freeze 
substitution p20  WT  xxx  o  xx  x     
A2418 
Freeze 
substitution p20  KO  xx  x  x  x     
                  
Processing : Detailed information on the processing is to be found in methods section     
                  
Age:  Post natal age (days)               
Type:  WT : wild type mouse               
  KO : plp null mouse               
Label:  The extent of gold particles associated with myelin with 2 different antibodies (i.e. PLP226 & PLPA) 
Background:  The extent of gold particles in the neuropil or in axons not associated with myelin     
                  
*** Abundant                 
** Moderate                 
* Few                 
o  none / poor quality precluding analysis           
-  not available for retrospective analysis             
 
  81   
CHAPTER 4    DISCUSSION 
The aim of this thesis was to evaluate subcellular immunohistochemical techniques for the purpose of 
studying myelin biology, specifically possible differential localisation of the transmembrane proteins 
PLP and DM20.   Two different types of immunological techniques (photo-oxidation and 
immunogold) to label PLP and DM20 at the subcellular level were investigated and it is clear that 
these both techniques have merits but are of limited utility for the study of myelin biology.   The two 
techniques produce quite different patterns of labelling.   The first technique (photooxidation) 
generates a very fine grainy and diffuse product that is too faint when applied to PLP antigen to be 
visualised at EM level other than in sections not contrast stained.   The second technique 
(immunogold) produces a well-defined electron dense particle that, depending on size, does not reach 
enough epitopes to produce a measurable result when conventional fixations are used.    
There are many problems to overcome when studying myelin.   The major challenge is the large 
amounts of lipid the compact myelin contains which make morphological preservation difficult.   
Lipids are extracted from the tissue during EM processing therefore requiring a strong fixation.   CNS 
myelin is commonly perfusion fixed with a glutaraldehyde concentration and acts by cross linking 
protein molecules leaving some free aldehyde groups tissue bound but still reactive.   This reactivity 
creates difficulty when histochemical solutions are introduced by forming non-specific fluorescent 
products i.e autofluorescence (Baschong et al, 2001).   Fluorescence photo-oxidation with eosin as 
performed by Deerinck et al, 1994 used low levels of glutaraldehyde.   Together with the fact that our 
laboratories had all equipment necessary, ease of use and that the experiment could be verified at LM 
level, this method was therefore chosen for my project. 
The challenge of ensuring adequate ultrastructural preservation of myelin constrained both the 
investigations of photo-oxidation and immunogold labelling.   With high concentrations (e.g. 5%) 
gluteraldehyde and paraformaldehyde excellent ultrastructure of myelinated fibres is achieved (see 
Griffiths et al, 1986, Fannaraga et al 1992, Yool et al, 2002, Edgar et al 2008 for published examples 
of this in my hands).   However, high concentrations of fixatives destroy or alter the antigen and 
successful immunohistochemical labelling has been achieved only with low/very low concentrations 
of fixative. 
Fixatives containing glutaraldehyde at markedly different concentrations were evaluated in this thesis 
and at concentrations of 1%, the integrity of the myelin was barely adequate (i.e. interperiod lines 
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were discernible).   Concentrations below this level leave CNS tissue very soft and prone to 
mechanical damage during handling.   At microscopic level the tissue is wavy with broken up myelin 
making it very difficult to find and recognise structures.   Being forced to use glutaraldehyde for 
morphological integrity, autofluorescence then had to be taken into account.   To reduce 
autofluorescence, sodium borohydride was tested and found to make a substantial difference in 
fluorescence emission (not reported).   The background emission was less and specific emission 
looked much sharper however the reaction when vibratome sections were incubated in sodium 
borohydride was very violent and broke up or curled the sections.   I decided not to pursue this option 
until the photo-oxidation method was established.   Having high background fluorescence was 
irrelevant at this point, the need to establish labelling was of greater importance. 
In the photo-oxidation studies, the minimal success of photo-oxidation analysis of myelin at the 
ultrastructural level contrasted with the excellent labelling achieved at the level of the light 
microscope.   The limited success of photo-oxidation at the ultrastructural level may be a consequence 
of either the sub-optimal conjugation of eosin with the secondary antibody or alternatively that the EM 
sections are too thin to hold enough antigens to be strongly labelled. Conjugating the fluorophore 
EITC onto the secondary antibody IgG was necessary since these were not commercially available.   
Three conjugations were performed and confirmed by SDS-PAGE electrophoresis, two with a goat-
anti-rabbit IgG and one with a goat-anti-rat IgG.   The anti-rabbit IgG conjugations were very 
successful.   Titres for the use of the two anti-rabbit IgG conjugations were independently tested first 
on oligodendrocyte cultures.   Cultures were used because they are readily available in our 
laboratories, and reduce the unnecessary use of animals.   The labelling of PLP in cell culture is 
excellent (Mitchell et al, 1992; Thomson et al, 2006).   The titres were then confirmed on CNS tissue 
sections.   The fluorescent labelling with EITC was estimated by visual inspection as emitting light at 
approximately 20% of that of FITC which was in concordance with published data (Deerinck et al, 
1994).   The anti-rat IgG conjugation was performed to be used in conjunction with an alternative 
primary antibody for labelling PLP/DM20, since the anti-rabbit antibody PLP226 previously used was 
of limited availability to me.   The primary antibody (AA3) used with the anti-rat IgG conjugation 
displayed a similar labelling to PLP226;  staining was fine (i.e. more specific) but signal was weaker. 
Photo-oxidation was easily carried out and easily recognised both during and after the procedure 
(Fig.3.5a & b, Fig.3.6), however the labelling was only apparent in LM sections.   Photo-oxidation 
with the EITC labelled PLP/DM20 failed to reveal any recognisable reaction product during electron 
microscopic observation in contrast stained sections.   A reaction product was only detectable in 
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sections where contrast staining was omitted and micrographs computer enhanced. Reasons for the 
faint PLP labelling could be the small amount of epitopes labelled in a thin section i.e. 70nm in an EM 
section compared to a section labelled for fluorescence microscopy of greater than10µm.  
The avidin-bitotin complex technique was used, prior to investigating unstained photo-oxidised 
sections, to try to establish the EM appearance of the DAB reaction product.   Photo-oxidation and 
DAB produce the same reaction production although it is less specific with photo-oxidation.   Again 
labelling at LM level was excellent but only astrocytes using anti-GFAP were visibly labelled at EM 
level.   When labelling with the ABC technique was strong enough to be seen easily, the morphology 
of the tissue deteriorated.   A possible explanation is that the reaction product becomes very hard 
compared to the rest of the tissue and is ripped out during sectioning (Buhl et al, 1993).   The ABC 
technique confirmed that the antigen must be heavily labelled to provide a DAB precipitate that can be 
easily visualised in the EM.   If the aim is to identify an antigen, preferably not a membrane bound 
molecule, and not as in our case to compare the differential labelling of two antibodies, the photo-
oxidation or the ABC technique then might be worth pursuing. 
The immunogold technique was chosen to evaluate if PLP/DM20 can be labelled at EM level because 
unlike the photo-oxidation technique the immunogold method produces specific and distinct reaction 
product.   Most published immunogold methods directed at myelin proteins employ protocols which 
avoid or use very weak concentration of glutaraldehyde (i.e. 0.1%) as fixative together with specialist 
embedding medium (Gershon et al 1994; Scherer et al, 1995; Hirst et al, 2000; Tait et al, 2000), 
ultracryostat sectioning (Trapp et al, 1989;  McLaurin et al, 1993;  Sobel et al, 1994;  Yin et al, 1998 
and 2006) or freeze fracture replica immunogold labeling (FRIL) (Li et al, 2002;  Nagy et al, 2004;  
Rash et al, 2004).   These methods are very successful but they require specialist equipment or 
expertise which was not available to me.   Conventional Durcupan ™ embedding medium and 
glutaraldehyde concentration of 1% for immunogold labelling in CNS tissue are used successfully by 
Prof. D. Maxwell’s group (Maxwell et al, 1995;  Maxwell and Ridell, 1999) and he kindly allowed me 
to learn their method in his laboratory for the possibility of labelling PLP/DM20.   One pre- and one 
post-embedding staining was carried out with the supervision and help of Mr Robert Kerr, a senior 
technician in Prof Maxwell’s laboratory, who is an authority in immunogold techniques as confirmed 
by co-authorships in published papers (e.g. Maxwell et al, 1997;  Pollock et al, 1997;  Sutherland et al, 
2002).   The pre-embedding technique revealed no specific staining of PLP/DM20.   The 
morphological preservation was unacceptable possibly due to the lengthy staining protocol and 
permeabilising treatment (Yi et al, 2001).   Furthermore the risk of cutting away labelled tissue, after 
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embedding, left this method less attractive for the time being.   The decision to concentrate on the 
post-embedding technique was taken because labelling of PLP/DM20 was present and morphology 
adequately preserved.   Myelin in these first sections from the post-embedding method was labelled 
although background, non-specific, staining was also present.   In order to improve specificity and 
morphology different approaches were attempted.   The formvar coated slot grids used caused 
wrinkling of the tissue due to surface expansion of the formvar film when sections are picked up and 
contraction when drying out with sections attached.   Uncoated 300 mesh grids were tested and 
showed improved immunogold labelling possibly because they were immersed during staining 
allowing solution access on both sides of the grid.   The negative effect was that the tissue was prone 
to breakage in the electron beam possibly due to the comparatively long staining procedure thus being 
exposed to strenuous handling.   The anatomical linear feature of longitudinally sectioned axons is 
also a weak physical aspect that renders tissue prone to breakage.   I therefore decided to sacrifice 
some resolution and persevere with intermittent wrinkling of sections by using formvar coated slot 
grids. 
Micro-filtering all solutions were also a prudent decision and eliminated some of the contamination.   
Filtering is practised by Mr R. Kerr during immunostaining but was omitted by me in the beginning 
due to the fact that normal EM staining does not require filtered solutions.   Immunological sera tend 
to be “dirty” but used widely at LM level.   Some potential labelling (at low magnification) could be 
eliminated as artefact by careful observation at high magnification due to the fact that gold particles 
are perfectly smooth, round and very dense in contrast to contamination debris which appears 
irregular, often translucent.     
A critical appraisal of the importance of fixation for immunogold labelling was conducted.   As 
mentioned previously, glutaraldehyde is necessary for reasonable preservation of myelin due to its 
high fat content although some antigenicity is lost (see Eldred et al, 1983).  The glutaraldehyde (1%) / 
paraformaldehyde (1%) fixative, previously used for the photo-oxidation with EITC method, provided 
the best preservation with the least concentration of glutaraldehyde.   Two additional fixatives to 
compare with the glutaraldehyde (1%)/ paraformaldehyde (1%) were tested.   Neither picric acid 
(15%)/glutaraldehyde (1%)/paraformaldehyde (1%) in phosphate buffer (0.1M) (Li et al, 2001), nor 
paraformaldehyde (4% )/glutaraldehyde (0.1%) in phosphate buffer (0.1M), (Tait et al, 2000) gave 
satisfactory morphological preservation   The decision to use the original fixative was taken because 
labelling of tissue using picric acid/glutaraldehyde/paraformaldehyde was only marginally better and 
the preservation definitely worse.   The immunostaining technique after paraformaldehyde (4%) / 
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gluteraldehyde (0.1%) was very different to the other two approaches;  specifically the buffers were 
different;  tannic acid was used as a pre-embedding stain, aldehyde quenching with ammonium 
chloride was employed, post-immunostaining fixation was achieved with stronger glutaraldehyde and 
osmium tetroxide.   The labelling with paraformaldehyde (4%) / gluteraldehyde (0.1%) was perhaps 
slightly less but background non-specific staining almost completely eliminated.   The major 
disadvantage of paraformaldehyde (4%) / gluteraldehyde (0.1%) was the very poor preservation of 
myelin which made this option unacceptable. 
Murine myelin production peaks at P20 (Verity and Campagnoni, 1988) and mice for the immunogold 
study were chosen after this age to ensure full myelination with abundant PLP protein.   The 
disadvantage with mature compact myelin is the large amount of lipid consequently making sufficient 
fixation a major problem.   I therefore decided to use younger animals between the ages P8 and P12.   
Myelination at this age is very active although myelin is not fully compacted (Mitchell et al, 1992) 
thus allowing improved fixation and perhaps greater access to the PLP/DM20 protein.   These animals 
showed a clearer picture of immunogold labelling although considerably reduced and sometimes 
absent.   The background staining was surprisingly also reduced.   The reason for this is difficult to 
determine.   Perhaps it is an effect of using detergent which is necessary to allow antibody penetration 
of membranes i.e. reactive membrane debris scattered around the myelin which would be increased in 
the mature animals where more compact myelin are available.   To increase penetration, the detergent 
(Triton X-100) is commonly used in immunostaining.   However the detergent “punches” holes in the 
membranes therefore destroying morphology.   Triton X-100 was reduced to a concentration of 0.1% 
to facilitate some degree of penetration (Priestley, 1984).   The use of medium (10nm) gold particles 
restrict penetration into the tissue therefore in order to increase labelling a smaller (2nm) gold particle 
was tested.   There was no visible labelling when used by itself, neither on sections contrast stained 
with uranyl acetate and lead citrate nor unstained sections.   Silver intensification of small gold 
particles has been used successfully for post-embedding staining (see Maxwell and many others) and 
allows visualisation at EM level.   However I found the silver intensification technique very difficult 
to control.   When silver intensification was used, particles became irregular and clumped together 
which then became difficult to differentiate from artefacts, or too large thus obscuring reaction sites.   
The smaller gold particle with silver enhancement confirmed that wild type PLP was labelled when 
compared with Plp1 null tissue (see Fig.3.18).   With more extensive investigations to establish 
reproducibility, this method could perhaps differentially label PLP and DM20. 
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When using older animals it was noted that particles often were more concentrated in broken up 
myelin suggesting that access to the PLP protein could be enhanced.   Accessibility to membrane-
bound antigens is a notorious problem and there are many different ways of dealing with it, the most 
common as mentioned before is to use a detergent.   Another option is to use freeze substitution in 
order to avoid initial water based, chemical fixation and embedding procedure that causes epitopes, 
particularly hydrophobic transmembrane molecules, to curl in on themselves thus preventing 
antibodies gaining access.   Water is substituted for acetone whilst tissue is still frozen leaving 
membranebound hydrofobic proteins immobile and unable to fold in on themselves during the 
dehydration.    Freeze substitution provided the best immunogold labelling.   Mature animals with 
maximum amount of myelin could be used and displayed intense labelling however neuropil 
surrounding and axonal tissue within compacted myelin was often disrupted.   The reproducibility and 
difficulty in finding nodes of Ranvier made this method only suitable for identifying antigens and not 
for a statistical analysis.     
Concluding comments and future work: 
There are disadvantages with all subcellular immunological techniques.   There are numerous 
publications on the use of subcellular immunological techniques in the CNS though their application 
to myelin protein is more limited.   This provides support for the view that this is a difficult area.   It is 
clear that one has to establish the research objectives for each study and reach compromises in a range 
of areas such as tissue preservation, antigenic preservation, size of label, specificity of label and 
accessibility to the antigen.   Neurological antigens situated in cell bodies and synapses are readily 
immunostained using simple immunological techniques.   However myelin is an exceptional 
neurological component and as such require special considerations.   These considerations included 
preservation of morphology without the destruction of antigenic epitopes of the protein of interest.   
The criteria for immunolabelling (I) The structure of tissue should be preserved (II) There should be 
differential labelling of myelin to non-myelin tissue were not met fully by any of the methods I looked 
at.   Although I have shown that myelin protein PLP and DM20 can be labelled using simple 
immunological techniques, differential labelling requires a specific antibody to DM20 alone in order 
to successfully quantify such a study or the employment of a more sophisticated method i.e. 
ultracryomicroscopy.    
At the outset, the rationale for this thesis was to establish an immunolocalisation technique which 
would allow the hypothesis to be tested that DM20 is expressed in non-compacted regions of the 
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myelinating oligodendrocyte, whilst PLP expression is confined to the compact myelin sheath. Thus 
the extracellular portion of DM20 may position at sites where the oligodendroglial cell is coming into 
close contact with other cells, specifically the axon, and consequently be involved in axon-glial 
interaction.   There are many differences (mainly the temporal expression pattern and structure) 
between the two isoforms that lends itself to this theory.  DM20 message is expressed prenataly 
whereas Plp 1 message has only been detected postnataly thus implicating different functions.The 
slight difference in structure of the two protein isoforms will perhaps affect how the protein behaves 
i.e. anchors to its specific site again implicating different functions. DM20 lacks exon 3B (encoding 
amino acid residues 117-129) which is predicted to contain anchoring sites leaving it with one instead 
of three such sites.   Studies with DM20 only expressing animals have shown a breakup of the 
intraperiod line which might be explained by its weakened anchoring ability.  This again suggests that 
the primary function for DM20 is not to uphold the compaction of myelin and would support the 
theory that DM20 solely might reside in the paranodal loops which are uncompacted. The paranodal 
loops play a strong role in axon/glia communication with specialisations such as sodium and 
potassium channels closely situated in the underlying axon making the paranodes a vital region of the 
myelin to study. PLP have been immunolocalised to compact myelin, in the CNS, by fluorescence 
microscopy technology and extracted CNS myelin has been shown to contain both isoforms. The 
likelihood that both isoforms positions in the compact myelin is generally accepted however without a 
specific antibody for DM20 alone this is just a hypothesis.  
One conclusion from this thesis is the importance of fixation and the constraint imposed on photo-
oxidation and immunogold labelling by the need to use high concentrations of gluteraldehyde to 
preserve integrity of myelin.   Although the original hypothesis could not be adequately tested with 
these immunological techniques to continue investigations of immunogold labelling of myelin, I have 
obtained support to attend a workshop on the use of ultracryomicroscopy for immunogold at the Max 
Planck Institute of Experimental Medicine in Göttingen, Germany.   Developing proficiency in 
ultracryomicroscopy (which has been used with success in ultrastructural analysis of myelin) would 
allow further exploration of differential labelling of PLP and DM20 without the constraints imposed 
by gluteraldehyde fixation. 
While immunogold labelling of myelin in the present thesis met with limited success at the 
ultrastructural level, immunogold labelling may have other utility in exploring demyelinating diseases. 
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I am currently collaborating with Prof. Michel Brahic, Department of Microbiology, Stanford 
University, CA, on a project to label Theiler’s murine encephalomyelitis virus (TMEV) using 
immunogold techniques.    TMEV affect neurons in grey matter but more importantly cause persistent 
infection of white matter, if animals are genetically susceptible, resulting in demyelination.  When 
injected into the eye the virus is transported in axons which are largely unaffected.  In contrast to the 
membrane bound proteins investigated in the present thesis the antibody being used targets epitopes 
on the surface of the virus and are therefore anticipated to be easier to label. 
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CHAPTER 5 APPENDICES 
5.1 GENERAL SOLUTIONS 
5.1.1 PHOSPHATE BUFFERED SALINE (PBS) 
Sodium  chloride    8g 
Disodium hydrogen phosphate  1.44g 
Potassium dihydrogen phosphate  0.24g 
Potassium  chloride    0.2g 
 
All ingredients were dissolved in 1litreb of dH2O and adjusted to pH 7.4 with 1M HCl.    
 
 
5.1.2 KARNOVSKY’S MODIFIED FIXATIVE 
Paraformaldehyde 4%, glutaraldehyde 5%. 
Preperation of 500 ml of the fixative: 
 
8% Paraformaldehyde: 
20 g of paraformaldehyde was added to 250 ml of dH2O and heated to 65°C. A few drops of 1M 
NaOH was added to clear and solution was allowed to cool. 
 
0.08M Cacodylate buffer:  
17.1224g sodium cacodylate was dissolved in a 1 litre of dH2O and adjusted to pH 7.2 with . 
 
 
8% paraformaldehyde   250 ml 
25% glutaraldehyde    100 ml 
0.08M cacodylate buffer  150 ml 
Calcium chloride    250 mg 
 
Liquid ingredients were mixed, calcium choride added and dissolved. The solution was  adjusted to 
pH 7.2, filtered and stored at 4˚C. 
 
5.1.3 DV BUFFER 
0.1% Triton X-100          100 µl  
0.2% pig skin gelatine      0.2g 
 
Ingredients were dissolved in 75 ml PBS on a hotplate and made up with PBS to a final volume of 
100ml. 
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5.1.4 ISOTONIC CACODYLATE BUFFER 
Sodium  cacodylate    16.05g 
Sodium chloride         3.8g 
Calcium chloride         0.055g 
Magnesium chloride         0.102g 
 
All ingredients were dissolved in dH2O and made up to final volume of 1 litre and adjusted to pH 7.2. 
 
5.1.5.   ARALDITE RESIN 
1.   Araldite CY212 (resin)          30g 
2.   Dodecanyl succinic anhydride (hardener)    25.2g 
3.   2,4,6-tri-dimethylaminomethyl-phenol (accelerator)  1.2 ml 
4.   Di-butylphthalate (plasticizer)     0.75  ml 
 
Ingredients 1 and 2 were placed in an oven at 65°C for 10 min. and mixed.   Ingredients 3 and 4 were 
added and stirred until homogenised. 
 
5.1.6 METHYLENE BLUE/ AZURE ΙΙ 
Preparation of 500 ml staining solution 
 
1% Borax:  
5g of sodium borate was dissolved in dH2O and made up to final volume of 500ml. 
 
5g of Methylene blue and 5g of Azur II was added to a flask, the volume was made up to 500ml with 
1% Borax. Solution was stirred, the flask capped and stored at RT. Small amounts of the solution was 
filtered and used as necessary. 
 
 
                                                                                                                      
5.1.7 REYNOLD’S LEAD CITRATE 
Lead Nitrate 1.33g 
Sodium citrate 1.76g 
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Each ingredient was dissolved in 15 ml dH2O, then combined and shaken vigorously from time to 
time over a 30 min.   period.   The solution was cleared with 8ml of 1M NaOH and made up to a final 
volume of 50 ml with dH2O. 
 
5.2 SOLUTIONS FOR PHOTO-OXIDATION 
 
5.2.1 PHOTO-OXIDATION BUFFER 
Triton  X-100      0.1ml 
Normal  goat  serum     2g 
Bovine serum albumin (fraction V)    2g 
Pig  skin  gelatine     0.2g 
 
 
Each ingredient was heated and dissolved in 25 ml dH2O and combined.   0.3g glycine was added 
before the solution was further diluted to 200 ml with 0.2 M sodium cacodylate buffer, pH 7.4. 
 
5.2.2 SDS-PAGE 
12.5% Acrylamide resolver gel: 
8.3 mls    acrylamide 
5.0 mls    1.5 M Tris pH 8.8 
200 µl     10% SDS 
150  µl    10% ammonium persulphate 
6.4 mls   dH2O 
10  µl      N,N,N’,N’-tetramethyl-ethylenediamine (Temed, Sigma) 
 
4 % Acrylamide stacker gel: 
880 µl acrylamide 
1.64 mls 0.5 M Tris pH 6.8 
30  µl 10% SDS 
75 µl 10 % ammonium persulphate   
4 mls   dH2O   
9 µl Temed 
 
3X SDS Denaturing Buffer: 
187 mM Tris pH 6.8 
6% SDS 
10 % Glycerol 
120 mM Dithiothreiotol (DTT) 
 
10X PAGE running buffer: 
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30.3 g Tris  
144 g Glycine 
10 g SDS 
Make up to 1 litre 
 
5.2.3 POLYETHYLENEAMINE COATED PETRIDISHES 
Stock solution: 
0.1% polyethyleneamine in dH2O 
 
A few drops of stock solution was added to the bottom of the specialised MatTek culture Petri dishes, 
swirled around to coat the whole cut-out circle and left for approximately two minutes before adding 
dH2O to rinse the dish which was then left to air dry for ~ 1 hour 
 
 
             
              
5.2.4 DURCUPAN RESIN 
Durcupan ACM™, EMS Catalog # 14040. 
Durcupan A: 
Epoxy resin     10 ml 
964 Hardener    10 ml 
964 Accelerator  0.3 – 0.4 ml 
Dibutyl phthalate (2)  0.1 – 0.2 ml 
 
Durcupan B: 
Epoxy resin     10 ml 
964 Hardener    10 ml 
Dibutyl phthalate (2)  0.1 – 0.2 ml 
 
The mixtures were heated to 50°C and stirred on a magnetic stirrer for a minimum of 30 minutes. 
 
 
5.3 SOLUTIONS FOR IMMUNOGOLD 
5.3.1 PHOSPHATE BUFFER (PB) 
Stock solutions: 
A. Sodium dihydrogen phosphate (NaH2PO4. 2H2O)   37.44  g/1200  ml 
  93   
B. Disodium hydrogen (Na2HPO4 anhydrous)    84.9 g/3000 ml 
 
0.2 M buffer: 
Solution A    1120 ml 
Solution B    2880 ml 
 
The solutions were combined and adjusted pH  7.4 
The buffer was diluted with other solutions as necessary to 1:1 for a final concentration at 0.1 M. 
 
 
5.3.2 MALEATE BUFFER 
Stock solution 0.2 M: 
Maleic acid (Sodium hydrogen maleate)  23.2 g 
Made up to 2 litres with dH2O and pH to 6.2 with 0.1 M NaOH. 
 
Stock solution was diluted as necessary with other solutions to a final concentration at 0.1 M. 
 
5.3.3 FORMVAR COATED GRIDS 
1% stock solution of formvar: 
1g of formvar was disolved in 100ml chloroform and stored in a dark glass bottle at RT in a fume 
cupboard.  
 
To coat grids: 
1. Stock solution was diluted 1:5 or 1:6 with chloroform and filtered. 
2. Cleaned glass slides were dipped in the solution, removed slowly and dried vertically. 
3. The edges of the slide was scraped with a razor blade and the formvar film floated on to a water 
surface (dH2O in a 1000ml beaker). Films with interference colour silver or silver/grey was selected.     
4. Slot or 200 mesh nickel grids, pre-cleaned in acetone, were gently placed on the film dull side down 
using a forceps.  
5. The films, loaded with grids, were recovered by placing a piece of Nescofilm™ on top of the film 
and picked up with a forceps, air-dried and stored in a Petri dish. 
 
 
 
5.3.4 PHOSPHATE BUFFERED SALINE with TRITON-X 100 (PBST). 
0.1 ml of Triton X-100 was added to100 ml of PBS (see 5.1.1) and gently heated until dissolved. 
 
5.3.5 TRIS BUFFERED SALINE with TRITON-X 100 (TBST) 
Stock solution 0.05M: 
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Tris(hydroxylmehtyl)methylanine   6.05g 
NaCl       8.5    g 
 
The ingredients were measured out, combined and dissolved in 750 ml of dH2O, adjusted to pH 8.2 
with 1 M HCl and kept at 4˚C. 
 
0.1 ml of Triton X-100 was added to 100 ml of stock solution and gently heated until dissolv
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